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Abstract 
 
Identifying Predictors of Medication Adherence in Adults Patients with Asthma:  
A Social Problem-Solving Approach 
 
Sara E. Voorhees 
 
Christine Maguth Nezu, Ph.D., ABPP 
Arthur M. Nezu, Ph.D., ABPP, D.H.L. (Hon.) 
 
 
 
 
 Asthma is a chronic respiratory illness that has become major public health concern 
due to its rapid increase in prevalence and increasing economic burden. Asthma 
management, which includes asthma control, perceived control of asthma and medication 
adherence, has been documented to be extremely poor. One of the main reasons for poor 
management includes low rates of medication adherence. The primary goal of this research 
study was to identify factors related to medication adherence that can eventually be 
integrated into clinical practice. Identifying these factors would help increase adherence 
rates and decrease the burden of asthma on individuals as well as the entire population.  
 The current study examined how individual variables are related to medication 
adherence in patients with asthma. Research has indicated that patients with high perceived 
stress are less likely to adhere to a prescribed medication regimen. Social problem-solving, 
which is the affective, cognitive and behavioral way individuals approach real world 
problems, is related to the management of various chronic conditions and may moderate the 
relationship between perceived stress and adherence outcomes. Adult asthma patients for 
this study were recruited from two different medical sites:  an allergy and asthma private 
practice located in New Jersey and Drexel Pulmonary Medicine located in Philadelphia, PA. 
Self-report data was collected from participants (N = 104) including demographic 
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information, asthma control, perceived control of asthma, perceived stress, social problem-
solving behaviors and medication adherence. Additional patient information was gathered 
using patient medical and pharmacy records. Bivariate correlational analyses demonstrated 
positive associations between perceived stress and dysfunctional social problem-solving 
tendencies and negative associations between perceived stress and self-report adherence. 
Lower perceived stress was also associated with more adaptive social problem-solving 
tendencies and higher asthma control. Lower perceived control of asthma was associated 
with the dysfunctional social problem-solving dimensions and higher pharmacy reports of 
adherence. Analyses also revealed relationships between higher self-report adherence and 
more adaptive problem-solving abilities. A hierarchical regression analysis revealed that 
lower perceived control of asthma was predictive of higher pharmacy refill adherence rates. 
Social problem-solving did not significantly moderate the relationship between perceived 
stress and medication adherence. Exploratory analyses indicated that lower self-reports of 
adherence, lower perceived control of asthma, and more maladaptive problem-solving 
tendencies were all predictive of higher perceived stress. Additionally, a one-way analysis of 
variance (ANOVA) was conducted to examine differences among racial and ethnic groups. 
Individuals who identified as White reported greater self-report adherence, less perceived 
stress, better social problem-solving abilities, higher perceived control of asthma, and better 
objective control of asthma, as compared to other racial and ethnic groups. Results suggest 
integrative medical and psychosocial treatments should be adapted for individuals of various 
racial and ethnic backgrounds. Interventions that target social problem-solving abilities and 
perceived stress may be particularly beneficial for improving patient’s ability and perceived 
ability to successfully manage their asthma.  
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1. Introduction 
 
 According to the Global Initiative for Asthma (GINA), there are currently more than 
300 million individuals worldwide with asthma. Asthma is a chronic respiratory condition 
that involves airway inflammation and airway obstruction, leading to symptoms such as 
coughing, wheezing, shortness of breath, chest pain, chest tightness and mucus production 
(GINA, 2012). This chronic illness has become a major public health concern due to its 
rapid increase in prevalence in the Western World. According to the Asthma and Allergy 
Foundation of America (AAFA), asthma prevalence has increased by 28% from 2001 to 
2011. Additionally, asthma poses a significant and increasing economic burden due to high 
treatment costs and emergency room visits.  
 Researchers estimate that asthma costs the United States about $56 billion per year, 
including both direct and indirect costs (United States Environmental Protection Agency, 
2013).  Hospital stays are responsible for a majority of the direct cost of asthma on the 
United States, with medications and general health care services also accounting for a large 
portion of that cost.  The Centers for Disease Control (CDC) state that patients with a 
primary diagnosis of asthma account for 10.5 million visits to physician offices and 1.8 
million visits to the emergency department per year. In terms of indirect expenses, it is 
estimated that lost productivity from missed days of work or school costs the United States 
$5.9 billion annually with about 1 in every 3 adults missing at least one day of work per year 
(Barnett & Nurmagambetov, 2011). These costs could be greatly reduced by minimizing 
hospitalizations and emergency room visits. Asthma is commonly placed among the top 5 
leading causes of preventable hospitalizations (Healthcare Cost and Utilization Project, 
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2015; Pappas, Hadden, Kozak, & Fisher, 1997), which is likely due to high levels of poor 
asthma management.  
 Numerous research studies have documented poor asthma management (Chapman, 
Boulet, Rea, & Franssen, 2008; Lavoie, Cartier, Labrecque, Bacon, Lemière, Malo, Lacoste, 
Barone, Verrier & Ditto, 2005). Asthma management typically includes 3 constructs:  
medication adherence, asthma control and perceived control of asthma (Cheung, LeMay, 
Saini, & Smith, 2014). Poorly managed asthma leads to high rates of emergency room visits, 
more frequent visits with physicians and daily disruptions in patients’ lives. According to 
the CDC, 3 in every 5 people limit their daily activities because of their asthma. Previous 
research has also found associations between various psychosocial factors and asthma 
management. Researchers have hypothesized that the way individuals cope with and manage 
their condition can greatly impact asthma outcomes. Specifically, patient’s attitudes and 
beliefs about their condition can influence outcomes from hospitalization rates (Adams, 
Smith & Ruffin, 2000) to asthma-related quality of life scores (Katz, Yelin, Eisner & Blanc, 
2002; Mancuso, Rincon, McCulloch & Charlson, 2001). Additionally, coping strategies for 
managing their chronic condition have a negative impact on asthma related well-being, 
including increased number of sick days and hospital admissions (Adams et al., 2000; 
Bosley, Corden, & Cochrane, 1996). Many researchers have also indicated that asthma 
patients show increased bronchoconstriction in response to stress (Affleck, Apter, Tennen, 
Reisine, Barrows, Willard, Unger, & ZuWallack, 2000; Ritz, Steptoe, DeWilde, & Costa, 
2000). Identifying and addressing these psychosocial factors is a major first step in 
developing comprehensive treatment plans for patients to effectively manage their asthma. 
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1.1 Medication Adherence 
 
Medication adherence is one of the important constructs that encompasses asthma 
management. Adherence, defined broadly, is the extent to which a person’s behavior 
corresponds with agreed-upon recommendations from a health-care provider (WHO, 2003). 
Medication adherence is vital for positive treatment responses and therefore keeping asthma 
symptoms under control. Recently, healthcare has shifted its focus by placing a greater 
emphasis on treatment outcomes. As a result, most providers forget about the mediating role 
that adherence has between treatment and outcomes (Brown & Bussell, 2011). Simply put, if 
patients are not taking their prescribed medications, they are not going to achieve optimal 
outcomes. Documented adherence rates tend to be extremely low. According to the 
American College of Preventive Medicine (ACPM), individuals with chronic conditions 
take only about half of their prescribed medication. In asthma specifically, research typically 
documents adherence rates between 30% and 40% (Windsor, Bailey, Richards Manzella, 
Soong, & Brooks, 1990).  
Physicians typically consider asthma patients to be “adherent” when they use their 
medication 80% of the time or more (Tan, Sarawate, Singer, Elward, Cohen, Smart, Busk, 
Lustig, O’Brien, & Schatz, 2009; Krishnan, Bender, Wamboldt, Szefler, Adkinson, Zeiger, 
Wise, & Bilderback, 2012), however, numerous research studies have documented poor 
adherence to prescribed asthma medications (Bender, Milgrom, & Apter, 2003; Sumino & 
Cabana, 2013).  Poor adherence is likely to lead to poor asthma control and increases in 
asthma exacerbations, which are associated with increased hospitalizations, leading to 
increased healthcare costs and risk of mortality. Some of the most commonly documented 
causes of nonadherence in asthmatics include anxiety regarding side effects, awkwardness 
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of inhaler use, denial of the severity of the illness, inadequate training in inhaler technique, 
lack of communication between patient and provider and forgetfulness (Brown & Bussell, 
2011; Gillissen, 2007). Addressing the primary causes of nonadherence in asthmatics would 
be a major first step in developing effective interventions to improve adherence rates.  
The National Heart, Lung and Blood Institute (NHLBI EPR-3) recommends 
treatment in the form of an inhaled corticosteroid (ICS) for patients with persistent asthma 
as the first line treatment. Inhaled corticosteroids are the most effective medications for 
long-term control of persistent asthma because the medication is inhaled directly into the 
lungs in order to reduce chronic airway inflammation (NHLBI, 2012). It is recommended 
that ICSs are taken daily as a preventive method to avoid asthma attacks and keep asthma 
symptoms under control. Since these medications should be taken daily, often patients will 
forget or decide to miss a dose, especially if they are not experiencing any symptoms. 
Research has also demonstrated that adherence is worse for inhaled medications as 
compared to oral medications (Tan, Sarawate, Singer, Elward, Cohen, Smart, Busk, Lustig, 
O’Brien, & Schatz, 2009), most likely due to the awkward nature or inconvenience of using 
an inhaler.  
 Detecting medication non-adherence remains a challenge in clinical practice because 
there are no standardized methods for assessing adherence behaviors. Cost effective 
methods include self-reports of adherence and clinician ratings, however, numerous research 
studies have stated that adherence is often greatly overestimated with self-report assessment 
methods (Brown & Bussell, 2011; Gillissen, 2007). Some objective measurement methods 
that have been used require electronic device monitors, review of pharmacy or medical 
records, and monitoring remaining doses by counting pills left in a bottle or weighing 
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inhaler canisters (Gillissen, 2007; Sumino & Cabana, 2013). Because self-report measures 
seem to be biased and inaccurate, more effective and easy methods for obtaining objective 
measures of adherence are needed. A multi-method approach is most effective for assessing 
medication adherence because significant differences are frequently found between 
subjective and objective reports of adherence, which have important clinical implications 
(Krishnan et al., 2012).  
1.2 Asthma Control 
 
 Aside from medication adherence, asthma control and perceived control of asthma 
are two key constructs of asthma management. According to the CDC, asthma control is the 
most important measure of overall asthma health. Additional research emphasizes that the 
goal of asthma treatment should always be optimum asthma control (Nathan, Sorkness, 
Kosinski, Schatz, Li, Marcus, Murray, & Pendergraft, 2004). Typical assessment of asthma 
control includes objective questions about asthma symptoms, such as insight into the 
occurrence of shortness of breath, use of rescue medications (short-acting bronchodilators) 
or the frequency of nighttime awakenings due to asthma. It is very common for physicians 
to assess asthma control during regular office visits so that they have an idea of their 
patients’ overall asthma health.  
Psychological factors are particularly important for the management of asthma, 
which is why perceived control of asthma is included within the construct of asthma 
management.  Perceived control of asthma refers to individuals’ perceptions of their ability 
to cope with asthma and its exacerbations. Self-efficacy, locus of control and learned 
helplessness are important for understanding perceived asthma control (Katz, Yelin, Eisner, 
& Blanc, 2002). Researchers report that a lack of confidence in managing one’s own illness 
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(low sense of asthma self-efficacy) increases anxiety, which can lead to asthma 
exacerbations and poor self-management skills (Katz et al. 2002; Taitel, Allen, & Creer, 
1998; van der Palen, Klein, & Seydel, 1997). Greater perceived control is also associated 
with better health outcomes and more engagement from patients in self-management 
behaviors, including increased rates of medication adherence (Buckelew, Huyser, Hewett, 
Johnson, Conway, Parker & Kay, 1996; Kempen, van Heuvelen, van Sonderen, van den 
Brink, Kooijman & Ormel, 1999; Rhee, Parker, Smarr, Petroski, Johnson, Hewett & Walker, 
2000; Smith, Christensen, Peck & Ward, 1994). These findings highlight that enhancing 
perceived control in asthma patients is likely to improve overall asthma management. 
1.3 Stress and Asthma 
 
The influence that stress has on physical illness is important to note. Psychological 
stress occurs when individuals appraise situations as being threatening or overwhelming 
along with the perception that adequate resources are not available to cope with the demands 
of the situation (Schneiderman, Ironson, & Siegel, 2005). Stress is commonly implicated in 
a variety of chronic illnesses due to its association with increased inflammation. Changes in 
emotional states, particularly negative changes, are accompanied by various changes in 
neuroendocrine and immunological functioning (Wright, Rodriguez, & Cohen, 1998). 
Recent advances in the field of psychoneuroimmunology can provide biological pathways 
for explaining the role of psychological stress in chronic illness.  
With asthma specifically, multidirectional pathways link psychological stress to the 
frequency, duration and severity of symptoms experienced by asthma patients (Rand, 
Wright, Cabana, Foggs, Halterman, Olson, Vollmer, Wilson & Taggart, 2012; Rietveld, 
Everaerd, & Creer, 2000). It is likely that these pathways have a physiological basis. Many 
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different cells and their associated cytokines play a part in the complicated immune 
processes that regulate atopic diseases such as asthma. Various hormones and neuropeptides 
are released when individuals are experiencing stress and these same hormones and 
neuropeptides are also involved in regulating both inflammatory and airway response 
processes (Wright et al., 1998). The increased inflammation that is experienced during stress 
leads to increased bronchoconstriction in asthmatics, which narrows the airways and results 
in decreased lung functioning (Rand et al., 2012). These overlapping biological pathways 
provide evidence that stress plays a major role in asthma as a chronic condition.  
Additional research suggests that perceived stress is strongly associated with asthma 
incidence and asthma hospitalizations. Rod, Kristensen, Lange, Prescott, & Diderichsen 
(2012) stated that high stress was associated with more than twice the risk of asthma and 
twice the risk of asthma hospitalization. Psychological stress is also likely to affect chronic 
illness on a behavioral level by greatly impacting how individuals self-manage their 
condition. In fact, stress is a risk factor for medication nonadherence in chronic conditions 
such as diabetes (Peyrot, McMurry, & Kruger, 1999), HIV (Gifford, Bormann, Shively, 
Wright, Richman, & Samuel, 2000), and asthma (Rand et al., 2012; Wright et al., 1998). 
Stress can also lead individuals to engage in adverse health behaviors such as poor diet, lack 
of physical activity and smoking (Rand et al., 2012). These health behaviors can serve as 
major triggers for asthma exacerbations. Additionally, researchers report that patients who 
experience chronic psychological stress do not respond as positively to asthma medication 
(Miller, Gaudin, Zysk, & Chen, 2009). Further, poorer outcomes to medications may lead to 
a sense of learned helplessness and increases in nonadherence. If patients do not believe that 
the medication is effective for them, they are likely to discontinue it. 
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The association between psychological stress and asthma has motivated researchers 
to include psychological interventions in treatment plans for asthma patients. Some of these 
interventions such as relaxation and guided imagery, cognitive stress-management, and self-
esteem workshops have been associated with improvements in respiration and immune 
functioning (Lehrer, Feldman, Giardino, Song, & Schmaling, 2002; Wright et al., 1998). 
The development of additional psychosocial interventions that target patient stress and self-
management of asthma are warranted to improve asthma outcomes.     
1.4 Social Problem-Solving 
 
 Social problem-solving (SPS) is defined as the interplay between affective, cognitive 
and behavioral factors in the process of identifying, discovering, and developing adaptive 
coping solutions for every day, real-life problems (Nezu, Nezu, & D’Zurilla, 2013). The 
construct of social problem-solving is made up of two distinct dimensions:  problem 
orientation and problem-solving style. Problem orientation refers to a set of cognitive-
affective schemas that characterize how individuals appraise and cope with problems. This 
dimension encompasses two independent types of problem orientation:  positive problem 
orientation (PPO) and negative problem orientation (NPO). Positive problem orientation 
(PPO) includes individuals with a strong sense of self-efficacy in terms of coping, a 
tendency to view problems as challenges that require time and effort to solve, and a positive 
appraisal of negative emotions as being helpful to cope with stressful problems. Individuals 
with a negative problem orientation (NPO) tend to perceive problems as immediate threats 
and do not believe they have adequate resources to solve or cope effectively with problems. 
These individuals also tend to get emotionally distressed in the face of difficult or stressful 
problems. Problem orientation may vary depending on the type of problem an individual is 
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experiencing. Individuals may be categorized as having a positive problem orientation 
towards some life problems, but could also have a negative problem orientation regarding 
other problems, such as coping with a chronic illness (Nezu et al., 2013). 
 Problem-solving style is described as the cognitive-behavioral strategies individuals 
engage in when attempting to solve or cope with stressful problems (Nezu et al., 2013). This 
dimension of social problem-solving is made up of three different styles including rational/ 
planful problem-solving (RPS), avoidant problem-solving (AS), and impulsive-careless 
problem-solving (ICS). Planful problem-solving style is an adaptive approach to cope with 
difficult problems. It includes defining the problem, outlining goals to problem-solving, and 
identifying barriers that may be in the way of successfully solving or coping with the 
problem at hand. In contrast, the additional two problem-solving styles (AS and ICS) are 
considered dysfunctional or maladaptive styles that tend to exacerbate current problems or 
generate new problems. Individuals characterized as having an avoidant problem-solving 
style (AS) are inclined to procrastinate and circumvent active problem solving by waiting to 
see if the problem will work itself out or if other individuals will jump in to help resolve the 
situation. Impulsive-careless style (ICS) is exemplified by a thoughtless, incomplete and 
hasty approach to solving problems without the development of specific goals or 
consideration of potential outcomes to impulsive decisions. Along with avoidant style and 
impulsive-careless style, negative problem orientation is considered to be a maladaptive 
dimension of problem-solving, while positive problem orientation and planful problem-
solving style are the adaptive dimensions that result in more effective problem-solving and 
lead to a variety of beneficial outcomes (Nezu et al., 2013). 
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 Impairments in problem-solving abilities have been associated with difficulties 
coping with chronic illnesses. Living with a chronic illness typically requires daily decision-
making and self-management skills. In addition to management regarding adherence to 
prescribed medications, patients make everyday decisions regarding what they are going to 
eat, if they are going to engage in physical activity, and whether or not they are going to 
engage in any adverse health behaviors such as smoking. Patients with chronic persistent 
asthma in particular must self-manage their condition by taking daily prescribed inhalers and 
avoiding negative health behaviors. These routine, daily decision-making processes require 
effective social problem-solving abilities for achieving optimal self-management of chronic 
illnesses (Bodenheimer, Lorig, Holman, & Grumbach, 2002). 
 While effective social problem-solving has yet to be adequately explored in asthma 
patients, it has been shown to be an important skill for a variety of chronic illness 
populations. For example, among patients recently diagnosed with cancer, individuals who 
engaged in problem-solving therapy had significantly lower scores of symptom limitation 
than participants in a control group (Doorenbos, Given, Given, Verbitsky, Cimprich, & 
McCorkle, 2005). Similarly, in a sample of patients with chronic pain, maladaptive problem-
solving was related to increased levels of pain, increased functional disability, and even 
higher depression scores (Kerns, Rosenberg, & Otis, 2002). Furthermore, among patients 
with diabetes, individuals with the most maladaptive problem-solving abilities had the 
highest levels of distress, which compromised their ability to effectively self-manage their 
illness (Elliott, Shewchuk, Miller, & Richards, 2001). Together, these findings suggest that 
effective social problem-solving abilities may alleviate symptom burden, decrease stress and 
improve overall control and management in asthmatics.  
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 Social problem-solving abilities may also play a role in medication adherence in 
patients with chronic illnesses. This specific association has not yet been adequately 
explored, however, problem-solving therapy has been used to foster the effectiveness of 
cognitive and behavioral intervention strategies. Researchers report that within an obese 
sample, participants in a problem-solving therapy group had significantly greater long-term 
weight reductions as compared to participants in control groups. It is possible that the 
behavioral strategies taught in the initial behavioral treatment phase of the intervention 
helped explained why participants who learned adaptive problem-solving abilities 
demonstrated better long-term adherence (Perri, Nezu, McKelvey, Shermer, Renjilian, & 
Viegener, 2001). Moreover, improvements in problem-solving abilities have been reported 
to mediate the relationship between treatment adherence and weight loss outcomes in a 
group of obese women. Researchers stated that adaptive problem-solving abilities were 
associated with greater weight reductions and better treatment adherence (Murawski, 
Milsom, Ross, Rickel, DeBraganza, Gibbons, & Perri, 2009). Problem-solving therapy may 
facilitate adherence because it helps patients cope with and overcome barriers that they may 
be experiencing. Some of these barriers stem from difficulties with motivation or actual skill 
deficits in overcoming obstacles related to adherence, including inadequate planning, missed 
physician visits, forgetfulness, and a lack of insight into illness. In sum, a social problem-
solving framework might provide insight into how and why cognitive-behavioral variables 
may be associated with higher rates of medication adherence among asthmatics.  
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2. Current Study 
 
2.1 Rationale 
 
 Despite numerous effective medications for asthma, management of this chronic 
condition remains suboptimal. Management tends to be poor due to extremely low rates of 
medication adherence in asthmatics. The current research study sought to determine 
associations between psychosocial factors and medication adherence and to identify factors 
that contribute to medication adherence. Identifying psychosocial variables that influence 
adherence levels is an important first step in designing effective interventions to improve 
medication adherence rates, and in turn improve asthma control and decrease mortality.  
2.2 Hypotheses 
 
2.2.1 Hypothesis 1: Correlational Analyses 
 
(1) It was hypothesized that Pearson product-moment correlational analyses would 
demonstrate significant associations among all dimensions of SPS and asthma control 
(ACT), perceived asthma control (PCAQ), perceived stress (PSS) and pharmacy reports 
of medication adherence.   
a. There will be positive associations among: 
i. Total scores on the SPSI-R:S and:  asthma control, perceived control, and 
medication adherence. 
ii. Adaptive dimensions of SPS (PPO and RPS) and:  asthma control, 
perceived control, and medication adherence. 
iii. Dysfunctional dimensions of SPS (NPO, ICS and AS) and perceived 
stress. 
b. There will be negative associations among: 
i. Total score on the SPSI-R:S and perceived stress. 
ii. Adaptive dimensions of SPS (PPO and RPS) and perceived stress. 
iii. Dysfunctional dimensions of SPS (NPO, ICS and AS) and:  asthma 
control, perceived control, and medication adherence.  
 
2.2.2 Hypothesis 2: Hierarchical Regression Analyses 
 
(2) Social problem-solving (SPS), asthma control (ACT), perceived asthma control (PCAQ) 
and perceived stress (PSS) would all significantly predict medication adherence, when 
controlling for demographic factors.  
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a. Asthma control, perceived asthma control and perceived stress would each 
account for a significant proportion of variation in pharmacy reports of 
medication adherence, when controlling for demographic factors.  
b. SPS would significantly predict medication adherence, above and beyond the 
variance accounted for by demographic factors, asthma control, perceived asthma 
control and stress.  
i. Higher scores on the adaptive SPS tendencies would predict better 
adherence. 
ii. Higher scores on the dysfunctional SPS tendencies would predict poorer 
adherence.  
 
2.2.3 Hypothesis 3: Moderation Analysis 
 
(3) Social problem-solving (SPS) would be a significant moderator of the relationship 
between perceived stress (PSS) and medication adherence, when controlling for 
demographic factors.  
a. It was hypothesized that adaptive SPS tendencies would attenuate the resulting 
impact of stress on pharmacy reports of medication adherence, when controlling 
for demographic factors.  
 
3. Methods 
 
3.1 Overview 
 
 The present study employed a cross-sectional self-report survey design to examine 
how patient-reported social problem-solving styles, asthma control, perceived control of 
asthma and perceived stress are related to asthma medication adherence. Participants were 
recruited in person from two locations:  Drexel Pulmonary Medicine, located in 
Philadelphia, PA and Atlantic Research Center, LLC, located in Ocean Township, NJ. 
Preliminary analyses were conducted to examine descriptive statistics on demographic 
variables, patient medical record information, and quantitative self-report measures. 
Additionally, Pearson product-moment correlations were conducted to examine initial 
relationships among all variables. Pearson product-moment correlations, hierarchical 
regression, and moderation analyses were conducted to examine planned hypotheses.  
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3.2 Participants 
 
 Eligible participants included individuals who were 18 years of age or older and had 
received a physician diagnosis of mild, moderate or severe persistent asthma. Participants 
were able to read and understand English on at least a 4th grade level. Patients were also 
prescribed a daily inhaled corticosteroid (ICS) for their asthma and were willing to give the 
research team permission to obtain information regarding prescription refills. Finally, 
participants agreed to participate and gave informed consent. Patients were considered 
ineligible if they were diagnosed with any other significant pulmonary diagnoses (e.g. 
COPD), smoked more than 10 pack years, and/or were pregnant. 
3.3 Measures  
 
3.3.1 Demographics. Basic demographic information was collected from 
participants, including sex, age, race/ethnicity, relationship status, number of children, years 
of education, household income, employment status, sexual orientation, health insurance 
provider and religious identity. Participants were also asked to provide health information 
including current medications, number of daily prescribed medications, smoking history, 
alcohol consumption, level of physical activity, current and past mental health problems, 
current and past treatment for psychological or emotional distress, and diagnoses of any 
additional medical conditions. The Charlson Age-Comorbidity Index (Charlson, Szatrowski, 
Peterson, & Gold, 1994) was used to obtain a comorbidity score for each participant, based 
on age and diagnoses of other medical conditions. Additional information collected about 
asthma included family history of asthma, previous hospitalizations and emergency room 
visits for asthma in the past and within the last year, number of previous intubations from 
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asthma in the past and within the last year, and how frequently patients see their physician 
for asthma. The site of participation was also recorded. 
3.3.2 Medical Record Information. Information was obtained from patient medical 
records and from the physician regarding individual’s specific asthma diagnosis (mild 
persistent, moderate persistent, or severe persistent), the patient’s primary physician at the 
site of participation and number of prescription refills. Specifically, the number of months a 
patient refilled his or her inhaled corticosteroid (ICS) prescription within the previous 12 
months was collected. The medication possession ratio (MPR) is a commonly used method 
for quantifying objective measures of adherence (Hess, Raebel, Conner, & Malone, 2006). 
Participants’ MPR was the number of times the prescription was filled divided by the period 
of time the patient has been prescribed the medication (not to exceed 1 year or 12 months) 
multiplied by 100. 
 3.3.3 Medication Adherence. In an effort to determine whether there are significant 
differences between pharmacy records of medication adherence and self-reports of 
medication adherence, the Medication Adherence Report Scale for Asthma (MARS-A) by 
Horne and Hankins (2002) was administered. Comprised of 10 items rated on a 5-point 
Likert scale from 1 (always) to 5 (never), the MARS-A assesses generic and asthma-specific 
medication use. Total scores are the average of 10 questions, with a total score of 5 
reflecting the highest adherence behaviors. Participants were asked to report their controller 
inhaler use. Specific items included “I only use it when I feel breathless”, “I forget to take 
it”, and “I stop taking it for a while.” The MARS-A has demonstrated good internal 
consistency (Cronbach’s α = .85) and principal component analyses have found that one 
factor accounts for most of the variance, suggesting that adherence is the only construct that 
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this assessment is measuring (Cohen, Mann, Wisnivesky, Horne, Leventhal, Musumeci-
Szabó, & Halm, 2009). 
3.3.4 Social Problem-Solving. Social problem-solving abilities were assessed using 
the 25-item Social Problem-Solving Inventory-Revised: Short form (SPSI-R:S) (D’Zurilla, 
Nezu, & Maydeu-Olivares, 2002). The SPSI-R:S provides a total score as well as subscale 
scores for each of the two problem orientation dimensions [positive problem orientation 
(PPO) and negative problem orientation (NPO)] and the three problem-solving styles 
[planful problem-solving style (RPS), impulsive/ careless style (ICS) and avoidant 
style(AS)]. The items are rated on a 5-point Likert scale ranging from 0 (not at all true of 
me) to 4 (extremely true of me), with higher total scores indicating more adaptive problem-
solving tendencies and higher scores on each dimension indicating increased use of the 
associated orientation of problem-solving. The SPSI-R: S has demonstrated good to 
excellent internal reliability across all five dimensions (Cronbach’s α = 0.79 - 0.95) and high 
test-retest reliability (r = 0.89 - .93) (D’Zurilla, Nezu, & Maydeu-Olivares, 2002).  
3.3.5 Asthma Control. Asthma control was measured with the 5-item Asthma 
Control Test (ACT) (Nathan, Sorkness, Kosinski, Schatz, Li, Marcus, Murray, & 
Pendergraft, 2004). This test is typically used in clinical practice as a way for physicians and 
patients to distinguish between poorly controlled and well controlled asthma. Items on this 
measure are rated on a 5-point Likert scale ranging from 1 (all of the time) to 5 (none of the 
time), with the highest score (25) indicating well controlled asthma. Examples items 
include:  “In the past 4 weeks, how much of the time did your asthma keep you from getting 
as much done at work, school or at home?” and “During the past 4 weeks, how often have 
you had shortness of breath?” The ACT has demonstrated good internal consistency 
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(Cronbach’s α = .84) and validity given its positive association with pulmonary function 
(Nathan et al., 2004). 
3.3.6 Perceived Control of Asthma. The Perceived Control of Asthma 
Questionnaire (PCAQ) is an 11-item questionnaire that was used to assess individuals’ 
perceptions of their ability to deal with asthma and its exacerbations (Katz, Yelin, Eisner, & 
Blanc, 2002). This overall construct represents self-efficacy, locus of control, and learned 
helplessness. Participants responded to a series of questions using a 5-point Likert scale 
from 1 (strongly disagree) to 5 (strongly agree), with higher scores indicating perception of 
greater control. Some of the items are reversed scored and the total score ranges from 11 to 
55. Select items from the measure include:  “I can reduce asthma by staying calm and 
relaxed”, “I have considerable ability to control my asthma”, and “It seems as though fate 
and other factors beyond my control affect my asthma.” The PCAQ has demonstrated 
acceptable internal consistency (Cronbach’s α = .76) (Katz et al., 2002).  
3.3.7 Perceived Stress. The Perceived Stress Scale (PSS) by Cohen, Kamarck, and 
Mermelstein (1983) was used to determine the degree to which individuals evaluate their 
lives as stressful. This scale is made up of 14 items that are rated on a 5-point Likert scale 
ranging from 0 (never) to 4 (very often). Example items include:  “In the last month, how 
often have you felt nervous and ‘stressed’?”, “In the last month, how often have you been 
able to control irritations in your life?”, and “In the last month, how often have you felt 
difficulties were piling up so high that you could not overcome them?”. The positively 
worded items on this scale are reverse scored and then all of the items are added to obtain a 
possible total score between 0 (no perceived stress) and 56 (the highest amount of perceived 
stress). The PSS has strong internal consistency (Cronbach’s α = .85) and adequate test-
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retest reliability (r = .55 - .85) (Cohen et al., 1983). 
3.4 Data Collection and Procedure 
 
 Participants for the current study were recruited in person from two research sites, 
including Drexel Pulmonary Medicine, an outpatient pulmonary clinic located at 219 N 
Broad Street in Philadelphia, PA and Atlantic Research Center, LLC, a private allergy, 
asthma and immunology practice located in Ocean Township, NJ. Physicians at each 
recruitment site determined participant eligibility. Flyers approved by Drexel University’s 
Institutional Review Board (IRB) were also posted in exam rooms and waiting areas to 
facilitate physician and patient self-referrals. In accordance with HIPAA, initial contact with 
eligible participants regarding study participation was made by the referring physician. If 
patients expressed interest in participating, the physician notified a trained research assistant 
who then entered the private exam room to obtain consent and administer the series of self-
report questionnaires. Upon completion, participants were compensated for their time and 
effort with $5.00 for their choice of 2 SEPTA tokens or a gift card to Starbucks, Target, or 
Amazon.  
3.5 Power Analysis 
 
Sample size for the current study was determined using G*Power 3.1 (Faul, 
Erdfelder, Lang, & Buchner, 2007). Hypothesis 2 required the largest sample size 
(hierarchical multiple regression); therefore, this analysis was used for computation of the 
required sample size. To be conservative, it was estimated that all 7 potential covariates 
(demographic variables) would be controlled for along with all 4 predictors (ACT, PCAQ, 
PSS and SPSI). Assuming a medium effect size (.15) and alpha set at .05, this analysis 
required a sample size of 118 to achieve power of .80. Based on the results of this power 
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analysis and the potential for attrition and missing data, the required sample size was 
increased by 25%. Therefore, the goal was to recruit 148 participants.  
Post hoc analyses were conducted to determine achieved power with the completed 
sample. One hundred four participants were recruited; however, pharmacy refill outcome 
data was only available for 71 participants. As discussed in the results section, four 
predictors and one covariate were included in the model for hypothesis 2. Based on this 
sample size, a medium effect size, and an alpha level of .05, achieved power for this 
hypothesis was .66. However, hypothesis one did achieve adequate power (.82). It is 
important to note that exploratory regression analyses were also adequately powered (.83).  
3.6 Ethical Considerations 
 
 The physician and researcher notified the patient that their participation was entirely 
voluntary. Data collection only continued once consent was obtained. Participants provided 
consent that the researcher would be able to access asthma medication prescription refills 
from pharmacy records. Numeric codes were assigned to each participant to maintain 
confidentiality and to ensure that no identifying information remained on the questionnaires. 
All confidential information was kept in locked filing cabinets in a secure lab office at 
Drexel University and solely trained members of the research team had access to these 
confidential files. Finally, research assistants all underwent extensive training to handle 
sensitive participant information. It is important to note that if participants experienced any 
mild psychological distress while responding to measures related to stress or health they 
were free to terminate participation of the study at any point without any consequences or 
impact on medical care they are receiving from the recruitment site. Reimbursement was 
provided regardless of whether or not the participant completed the entire study and 
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participants were encouraged to ask questions or contact additional members of the research 
team with any questions or concerns. 
4. Results 
 
Data were analyzed using the Statistical Package for the Social Sciences (SPSS), 
version 24. Preliminary analyses were conducted to examine characteristics of participants 
and to determine relationships among primary variables. Statistical analyses, as described 
below, were conducted to evaluate planned hypotheses and exploratory analyses. 
Assumptions of all proposed statistical analyses were examined and addressed prior to 
statistical examination. Complete datasets were defined as those in which the participant 
answered all questions for the outcome measures relevant to the hypotheses being tested.  
4.1 Participant Characteristics  
4.1.1 Participant Demographics 
Descriptive statistics for all demographic variables were examined (see Table 1). The 
achieved sample size for this study was 104 participants, with 64 (61.5%) patients from 
Drexel Pulmonary Medicine and 40 (38.5%) patients from Atlantic Research Center, LLC. 
A majority of the participants in this sample were female (n = 78; 75%) and identified as 
White (n = 51; 49%). The remaining participants identified as Black/ African American (n = 
39; 37.5%), Hispanic/ Latino (n = 7; 6.7%), Multiracial (n = 3; 2.9%), Asian (n = 2; 1.9%), 
Native Hawaiian/ Pacific Islander (n = 1; 1.0%), and Other (n = 1; 1.0%). The most common 
relationship status for participants was married or living with a partner (n = 51; 49%) and a 
majority reported that they have children (n = 75; 72.1%). The mean age of participants was 
51.85 years old with a standard deviation of 15.77 and a range of 18 – 78 years old.  
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The most frequently reported religious identities were Catholic (n = 35; 33.7%) and 
Christian (n = 32; 30.8%) and most participants reported being somewhat religious (n = 55; 
52.9%). Responses ranged in terms of estimated annual household income, level of 
education, and employment status. The greatest percentage of participants reported that they 
earn less than $20,000 (n = 30; 28.8%) while the next greatest percentage reported that they 
earn more than $100,000 (n = 28; 26.9%). Regarding employment status and level of 
education, a sizable group of participants are currently working full-time (n = 35; 33.7%) or 
are disabled/ unable to work (n = 29; 27.9%) and most have earned a college degree (n = 32; 
30.8%). The most common types of health insurance were employment-based private plan 
(n = 49; 47.1%) and Medicare (n = 41; 39.4%). 
4.1.2 Participant Health/ Medical Record Demographics 
 Descriptive statistics were examined for participant health variables and medical 
record information (see Table 2). Most participants never smoked or used tobacco products 
(n = 73; 70.2%) and never drink alcohol (n = 48; 46.2%). In terms of mental health, a 
majority of the sample reported that they have never suffered from or been diagnosed with a 
mental health problem (n = 79; 76.0%). For more than half of the participants, neither parent 
had been diagnosed with asthma (n = 54; 51.9%), while nineteen participants reported that 
their mother had asthma (18.3%) and thirteen participants reported that their father had 
asthma (12.5%). Most participants visited the emergency room (n = 55; 52.9%) for their 
asthma. Regarding diagnosis, a majority of the participants had either moderate persistent 
asthma (n = 47; 45.2%) or severe persistent asthma (n = 43; 41.3%).  
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4.2 Preliminary Analyses 
 
4.2.1 Descriptive Statistics of Primary Variables 
 
 See Table 3 for descriptive statistics on all quantitative study measures. The primary 
variables of interest included pharmacy refill data, asthma control, perceived asthma control, 
self-report medication adherence, perceived stress and social problem-solving.  
 Pharmacy refill information was measured by calculating the number of times the 
patient filled their prescription within the previous 12 months. The mean for pharmacy 
refills, as assessed using the medication possession ratio (MPR), was 4.94 refills with a 
standard deviation of 4.06 and a range of 0 – 12. Higher scores represented more 
prescription refills and greater medication adherence. Skewness was determined to be .651, 
with a standard error of .285, indicating a significantly positively skewed distribution based 
on the Kolmogorov-Smirnov test of normality (p < .001). The Kolmogorov-Smirnov test is 
used for sample sizes greater than fifty (Field, 2013). A distribution with a positive skew has 
more scores that fall closer to the left of the distribution than to be expected in a normally 
distributed sample. For this variable, the positively skewed distribution suggests that many 
participants had pharmacy refill scores that clustered below the average of a normally 
distributed sample. Sample size for this variable was also limited due to incomplete 
availability of pharmacy information on many patients. 
 The mean for asthma control, as measured with the Asthma Control Test (ACT), was 
16.99 with a standard deviation of 6.01 and a range of 5 – 25. Higher scores represent 
greater objective asthma control, with scores below 19 indicating poorly controlled asthma 
(Nathan et al., 2004). Skewness was determined to be -.212, with a standard error of .285, 
indicating a significantly negatively skewed distribution based on the Kolmogorov-Smirnov 
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test of normality (p < .05). A distribution with a negative skew has more scores that fall 
closer to the right of the distribution than to be expected in a normally distributed sample. In 
terms of this asthma control, the negatively skewed distribution suggests that many patients 
in this study had asthma control scores that clustered above the average of a normally 
distributed sample.  
 The mean for perceived asthma control, which was assessed using the Perceived 
Control of Asthma Questionnaire (PCAQ), was 39.18 with a standard deviation of 8.48 and 
a range of 17 – 55. Higher scores indicate greater perceived control of asthma. Based on the 
Kolmogorov-Smirnov test of normality, this distribution was normally distributed (p > .05).   
 The mean for self-report medication adherence, as measured with the Medication 
Adherence Report Scale for Asthma (MARS-A), was 4.23 with a standard deviation of 0.83 
and a range of 1.6 – 5. Higher scores indicate greater self-reports of medication adherence. 
Skewness was determined to be -1.02, with a standard error of .285, indicating a 
significantly negatively skewed distribution (p < .001). A negatively skewed distribution has 
more score that fall to the right of the distribution than to be expected in a normally 
distributed sample. Regarding self-report medication adherence, this distribution suggests 
that many patients in this study had adherence scores that clustered above the average of a 
normally distributed sample.  
 The mean for perceived stress, as measured with the Perceived Stress Scale (PSS), 
was 21.58 with a standard deviation of 8.02 and a range of 3 – 46. Higher scores indicate 
greater levels of perceived stress in patients. Based on the Kolmogorov-Smirnov test of 
normality, this distribution was normally distributed (p > .05).   
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 The mean for social problem-solving, as assessed using the Social Problem-Solving 
Inventory-Revised: Short Form, was 13.95 with a standard deviation of 2.63 and a range of 
8.2 – 18.6. Higher scores indicate more adaptive social problem-solving tendencies. Based 
on the Kolmogorov-Smirnov test of normality, this distribution was normally distributed (p 
> .05).   
4.2.2 Initial Associations 
 
Bivariate correlation coefficients were computed among primary variables and 
demographic factors to determine if any factors should be controlled for in the main 
analyses and to check for multicollinearity. Based on previous literature, potential covariates 
might include sex, age, education, income, employment status, marital status and parental 
asthma (Rod, Kristensen, Lange, Prescott, & Diderichsen, 2012). None of these factors were 
significantly correlated with the outcome of medication adherence, however, significant 
differences were found in the study outcomes based on race. Therefore, race/ethnicity was 
the only demographic factor that was controlled for in the main analyses. Additionally, none 
of the variables had correlation coefficients greater than .7, indicating that multicollinearity 
was not an issue for the main regression analyses. Pearson product-moment correlational 
analyses revealed a positive association between both measures of asthma control:  
perceived control of asthma and objective asthma control (r = .57, p < .01). Interestingly, 
both measures of adherence (self-report and pharmacy refills) were also positively correlated 
with each other (r = .31, p < .01) (see Table 4). 
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4.3 Main Analyses 
 
4.3.1 Hypothesis 1 
 
 The first hypothesis stated that correlational analyses would demonstrate significant 
associations between dimensions of social problem-solving with asthma control, perceived 
asthma control, perceived stress and pharmacy reports of adherence. Hypothesis one 
employed Pearson product-moment correlations to examine relationships among these 
primary variables (see Table 4). Correlations between the following variables were 
examined:  medication adherence based on pharmacy refill data (MPR), perceived control of 
asthma based on the PCAQ, objective asthma control based on the ACT, perceived stress 
based on the PSS, self-report adherence based on the MARS-A, PPO (positive problem 
orientation) subscale of the SPSI, NPO (negative problem orientation) subscale of the SPSI, 
RPS (rational/ planful style) subscale of the SPSI, ICS (impulsive/ careless style) subscale of 
the SPSI, AS (avoidant style) subscale of the SPSI, and total social problem-solving scores 
based on the SPSI-R:S.  
 Pearson product-moment correlational analyses revealed positive associations 
between stress and negative problem orientation (r = .51, p < .01), impulsive-careless style 
(r = .32, p < .01), and avoidant style (r = .41, p < .01). Stress was negatively correlated with 
self-report medication adherence (r = -.27, p < .01), positive problem orientation (r = -.20, p 
< .05), and total social problem-solving scores (r = -.53, p < .01). Stress was also negatively 
correlated with perceived control of asthma (r = -.40, p < .01) and objective asthma control 
(r = -.21, p < .05). In addition, negative correlations were found between perceived control 
of asthma and negative problem orientation (r = -.22, p < .05), impulsive-careless style (r = -
.20, p < .05) and avoidant style (r = -.23, p < .05). Similarly, objective asthma control was 
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negatively correlated with negative problem orientation (r = -.22, p < .05) and avoidant style 
(r = -.26, p < .01). Moreover, perceived control of asthma was negatively correlated with 
pharmacy refill adherence (r = -.31, p < .01). Self-report medication adherence was 
negatively correlated with negative problem orientation (r = -.22, p < .05), impulsive-
careless style (r = -.22, p < .05), and avoidant style (r = -.30, p < .01), and positively 
correlated with total social problem-solving scores (r = .20, p < .01). In sum, higher 
perceived stress was associated with higher scores on all three dysfunctional dimensions of 
social problem-solving (NPO, ICS, and AS) and lower self-report adherence rates. Higher 
scores of positive problem orientation and higher total social problem-solving scores were 
associated with lower perceived stress. In addition, higher scores on both measures of 
asthma control were associated with lower levels of stress. Higher scores on the 
dysfunctional dimensions of social problem-solving were also associated with lower 
perceived control of asthma, while higher scores on negative problem orientation and 
avoidant style were associated with lower objective asthma control. Surprisingly, higher 
pharmacy refill rates were associated with lower perceived control of asthma. In terms of 
self-report adherence, high adherence was associated with lower scores on all three 
dysfunctional dimensions of social problem-solving and higher total scores of social 
problem-solving.  
4.3.2 Hypothesis 2 
 
 The second hypothesis stated that social problem-solving, asthma control, perceived 
control of asthma and perceived stress would all significantly predict pharmacy reports of 
medication adherence, when controlling for necessary demographics. Hierarchical 
regression analysis was used to examine these primary variables and how they impact 
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medication adherence. All potential demographic covariates were planned to be entered into 
block one to control for these variables. Since the only demographic variable that was 
associated with the outcome of pharmacy refill data was race/ethnicity, this was the only 
covariate entered into block one. Perceived stress was then entered into block two and both 
measures of asthma control (perceived and objective) were entered into block three. Finally, 
social problem-solving was entered into block four to determine how much variance this 
variable is explaining in medication adherence, above and beyond the variance accounted 
for by covariates, perceived stress and asthma control.  
 A hierarchical regression analysis was conducted to determine which variables were 
significant predictors of medication adherence based on pharmacy refill information. Model 
one, including race/ethnicity as the predictor, was not significant in explaining variance in 
pharmacy refill data. Model two, which added perceived stress to the model, was also not 
significant. Objective asthma control and perceived control of asthma were added into 
model three. This model was significant in explaining variance in pharmacy refill 
medication adherence, F(4, 66) = 4.223, p < .01. Specifically, lower perceived control of 
asthma was associated with higher rates of adherence (see Table 5). In the fourth model, 
social problem-solving was included. Overall, this fourth model was significant, F(5, 65) = 
3.969, p < .01, however, social problem-solving did not emerge as a significant predictor of 
pharmacy refill data. In this final model, only race/ethnicity and perceived control of asthma 
were significant predictors (see Table 5).  
4.3.3 Hypothesis 3 
 
 The third hypothesis evaluated whether the relationship between stress and 
medication adherence was moderated by social problem-solving abilities. This hypothesis 
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was assessed with a moderation analysis using PROCESS (Hayes, 2013). A moderation 
occurs when the relationship between two variables changes in direction or strength as a 
function of a third variable (Field, 2013). PROCESS is an add-on program for SPSS that 
uses a linear regression-based analytic framework to analyze mediation and moderation 
analyses (Hayes, 2013).  
 The overall model for perceived stress and social problem-solving predicting 
medication adherence based on pharmacy refill data was not significant. Results indicated 
that social problem-solving did not serve as a significant moderator for the relationship 
between perceived stress and medication adherence.  
4.4 Exploratory Analyses  
 
 Additional analyses were conducted to examine which variables are predictive of 
stress in asthma patients. A hierarchical regression analysis was used to examine which of 
the primary variables (medication adherence, objective asthma control, perceived control of 
asthma, and social problem solving) predict perceived stress in patients with asthma. Since 
the sample size was low for pharmacy refill adherence, self-report assessment of adherence 
was used as the medication adherence measure in this statistical test. Correlational analyses 
revealed that race/ethnicity and income were both significantly associated with perceived 
stress, therefore, these demographic variables were entered into block one of the hierarchical 
regression as a way of controlling for them in the analysis. Self-report adherence was then 
entered into block two, objective asthma control and perceived control of asthma were both 
entered into block three, and social problem-solving was entered into block four.  
 A hierarchical regression indicated that the model for self-report adherence 
predicting perceived stress when controlling for race/ethnicity and income was significant, 
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F(3, 94) = 6.581, p < .01. Specifically, lower self-report of medication adherence was 
predictive of higher perceived stress (see Table 6). Model three, which added both measures 
of asthma control, was also significant, F(5, 92) = 6.970, p < .001. Perceived control of 
asthma emerged as a significant predictor of stress, such that those reporting lower 
perceived control of asthma were more likely to report higher levels of perceived stress. The 
overall model including social problem-solving, both assessments of asthma control, and 
self-report medication adherence, when controlling for race/ ethnicity, was significant F(6, 
91) = 12.604, p < .001. In this final model, perceived control of asthma and social problem-
solving both emerged as significant predictors of perceived stress (see Table 6). Results 
indicated that social problem-solving abilities significantly predicted stress, above and 
beyond variance accounted for by demographic factors, asthma control, and medication 
adherence, such that poorer social problem-solving abilities were associated with higher 
levels of perceived stress.   
A one-way analysis of variance (ANOVA) was also conducted to examine how the 
outcome variables (i.e., pharmacy refill adherence, self-report adherence, perceived stress, 
social problem-solving, asthma control, and perceived control) differed as a function of 
race/ethnicity. Fifty-one individuals identified as White and 39 individuals identified as 
Black/African-American. Because of the small sample sizes for American Indian/Alaska 
Native, Asian, Native Hawaiian/Pacific Islander, Hispanic/Latino and Multiracial, these 
groups were combined into a category labeled “Other” (n = 14). ANOVAs indicated 
significant differences among racial/ethnic groups for all outcome variables except 
pharmacy refill data (see Table 7).  
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 Bonferroni post-hoc analyses were conducted on each outcome to determine specific 
differences between groups. Individuals who identified as White (M = 4.488, SD = .737), 
reported significantly higher self-report adherence than individuals who identified as 
Black/African-American (M = 4.077, SD = .827), p = .048, as well as individuals who 
identified as Other (M = 3.736, SD = .865), p = .006 (see Table 8). On perceived stress, 
individuals who identified as Other (M = 28.214, SD = .8.322), reported significantly higher 
scores than individuals who identified as White (M = 20.200, SD = 6.975), p = .002, as well 
as individuals who identified as Black/African-American (M = 20.947, SD = 8.200), p = 
.006. Individuals who identified as White (M = 14.756, SD = 2.201), reported significantly 
higher social problem-solving scores than individuals who identified as Other (M = 12.300, 
SD = 2.632), p = .005. In terms of objective asthma control, individuals who identified as 
White (M = 19.284, SD = 5.886), reported significantly higher scores than individuals who 
identified as Black/ African-American (M = 15.436, SD = 5.113), p = .005, as well as 
individuals who identified as Other (M = 13.000, SD = 5.602), p = .001. Finally, individuals 
who identified as White (M = 41.431, SD = 8.638), reported significantly higher scores on 
perceived control of asthma than individuals who identified as Other (M = 34.857, SD = 
7.502), p = .029 (see Table 8).  
5. Discussion 
 
5.1 Purpose 
 
 Asthma is a serious chronic illness that is typically poorly managed given the low 
rates of medication adherence and poor asthma control. Research has demonstrated that 
asthma patients show increased asthma symptoms in response to psychosocial factors such 
as high stress and negative coping skills (Ritz, Steptoe, DeWilde, & Costa, 2000). Little 
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research has addressed psychosocial aspects of asthma, specifically their relationship with 
asthma management techniques like medication adherence. Focusing on these psychosocial 
factors is an important step towards developing effective integrative treatment plans for 
patients with asthma.  
The current study aimed to build upon and extend the current literature by examining 
psychological factors of asthma and medication adherence. Patients in this study reported 
demographic factors, medical record information regarding asthma diagnosis and 
prescription refills, self-reports of asthma medication adherence, objective asthma control, 
perceived control of asthma, perceived levels of stress, and social problem-solving 
tendencies. This study examined psychological factors that are associated with a diagnosis 
of asthma and medication adherence. Social problem-solving was assessed as a moderating 
variable and exploratory analyses were conducted to examine which factors explain 
perceived stress in asthma patients as well as differences in outcomes as a function of race/ 
ethnicity. 
5.2 Participant Characteristics 
 
The sample consisted of mostly White middle-aged married women who are working 
full-time (see Table 1). The sample, however, was very diverse due to the demographic 
differences between participants recruited from Drexel Pulmonary Medicine and Atlantic 
Research Center, LLC (see Table 1). More than half of the sample from Drexel Pulmonary 
Medicine were Black/African American women and most of the sample had not received 
above a high school education. Moreover, these participants were mostly disabled or unable 
to work and had an estimated annual household income of below twenty-thousand dollars. 
Among these participants, there was almost an even split of those who are married or living 
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with a partner and those who are single. In contrast, the participants from Atlantic Research 
Center, LLC, were mostly highly educated White women with an estimated annual 
household income of above one-hundred thousand dollars. A majority of these participants 
reported that they work full-time and are married or living with a partner. Most of the 
participants from both sites have children and identify as Catholic or Christian. The 
differences between recruitment sites were expected based on the inner-city setting of 
Drexel Pulmonary Medicine and the suburban, upper-class nature of Atlantic Research 
Center, LLC.  
Most participants in this sample had never smoked or used tobacco products and 
rarely drink alcohol. The lack of tobacco use is likely a result of the exclusion criteria, 
preventing heavy smokers from participating in the study. Additionally, the participants 
reported engaging in moderate levels of physical activity and most have never been 
diagnosed with any mental health diagnoses. Of those who had been diagnosed with mental 
health problems, the most frequent forms of psychological treatment were individual 
therapy, couple’s therapy and prescription medication. More than half of the sample 
reported that neither one of their parents had asthma. Of those whose parents did have 
asthma, more participants reported maternal asthma, which the literature indicates is a 
stronger risk factor for asthma than paternal asthma (Sears, Holdaway, Flannery, Herbison, 
& Silva, 1996). Most of the participants from Atlantic Research Center, LLC, were never 
hospitalized nor visited the emergency room for their asthma, while about half of those from 
Drexel Pulmonary Medicine had been hospitalized and visited the emergency room for an 
asthma exacerbation. These results may be explained by the fact that a majority of the 
patients from Drexel Pulmonary had a diagnosis of severe persistent asthma, while most 
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patients from Atlantic Research Center, LLC, were diagnosed with moderate persistent 
asthma. Overall, very few patients had a diagnosis of mild persistent asthma. The plurality 
of participants in this sample reported that they see their physician at least every six months 
for their asthma, which is in line with recommendations from health care professionals 
(NHLB, 2012).  
5.3 Preliminary Analyses 
 
5.3.1 Descriptive Statistics on Primary Variables 
 
 Descriptive statistics of all self-report and medical record assessments were 
examined. Pharmacy refill data based on the medication possession ratio (MPR) ranged 
from the lowest possible score of 0 to the highest possible score of 12. This means that some 
patients had not filled their inhaled corticosteroid prescription at all within the previous 12 
months, while other patients had filled their prescription every month throughout the year. 
The mean number of prescription refills for this sample was 4.94 times. In other words, most 
patients filled their controller inhaler less than half of the prescribed amount. This variability 
was positively skewed, which means many participants had pharmacy refill scores that 
clustered below the average of a normally distributed sample. The low rates of adherence in 
this sample are in line with extant literature – medication adherence rates for asthma patients 
tend to be extremely poor (Bender, Milgrom, & Apter, 2003; Sumino & Cabana, 2013). 
Sample size was limited for the pharmacy refill variable since pharmacy information was 
not attainable for a subset of patients in the sample. Many individuals use home delivery 
pharmacy services and therefore refill information could not be obtained for these patients. 
Additionally, physicians often give sample inhalers to patients for a variety of reasons, such 
as testing out a new inhaler or providing patients with samples of an inhaler their insurance 
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does not cover. Because this information was not documented by the pharmacy, sample 
inhaler use was not accounted for by this adherence measure. Furthermore, patients tend to 
use multiple different pharmacies and may switch between different inhaler prescriptions 
based on insurance coverage or patient preference. In this study, not all pharmacy or 
prescription information was available, which may have led to underreporting of refill rates.  
 Asthma control, as measured by the Asthma Control Test (ACT), ranged from a 
score of 5 (the lowest possible score) to 25 (the highest possible score). The distribution was 
negatively skewed compared to a normal distribution, meaning that patients reported better 
than average asthma control. Despite this negative distribution, however, the average score 
was 16.99, which still falls under the cutoff of 19 indicating poorly controlled asthma. The 
cutoff on this measure for poorly controlled asthma is relatively high, which suggests that 
the numerical average score of a normal distribution would still indicate extremely poor 
asthma control. One reason for higher than average reported asthma control scores could be 
due to the fact that most patients in this study were being seen by the physician for an 
outpatient, routine follow-up appointment. As a result, it is unlikely that they were 
experiencing exacerbated asthma symptoms at the time of this visit. Additionally, because 
this was an in-person study at a physician’s office, patients may have been engaging in 
social desirability bias. 
 Perceived asthma control was measured using the Perceived Control of Asthma 
Questionnaire (PCAQ), which assesses individuals’ perceptions of their ability to deal with 
asthma and its exacerbations. Scores on this measure ranged from 17 to 55, with higher 
scores indicating perception of greater control of asthma. This distribution was found to be 
normal, meaning that participant scores were evenly spread across the distribution. 
   35 
According to this measure, there was a range of responses in perceived control of asthma, 
suggesting that patients vary in their levels of self-efficacy, locus of control and learned 
helplessness related to their asthma management.   
 The Medication Adherence Report Scale for Asthma (MARS-A) was also used to 
assess self-report medication adherence. Scores on this measure ranged from 1.6 to 5 (the 
highest possible score), with a negatively skewed distribution indicating higher than average 
self-report adherence. The high self-report scores of medication adherence in this study are 
in line with previous research suggesting that adherence is greatly overestimated with self-
report assessment (Brown & Bussell, 2011; Gillissen, 2007). Again, it is very likely that 
social desirability bias played a role in the outcome of this assessment since patients want to 
appear more adherent to their medications than they probably are. While in the physician 
exam room, it is easy to assume that patients overestimated their levels of adherence. 
Patients also may not recognize their non-adherent behaviors, such as forgetting to take their 
inhaler or taking less than instructed. It is worth noting that there was probably a ceiling 
effect with this assessment since numerous patients reported perfect adherence and the mean 
(4.23) is very close to the maximum possible score.  
 Perceived stress, which was assessed using the Perceived Stress Scale (PSS), ranged 
dramatically within the sample (3 – 46). The scores for this measure fell along a normal 
distribution indicating that participant scores did not cluster towards either end of the 
distribution. Participants ranged from very little perceived stress to great amounts of 
perceived stress, with most scores clustering around the mean.  
 Social Problem-Solving, which was assessed by the Social Problem-Solving 
Inventory-Revised: Short Form (SPSI-R:S), was normally distributed. Participant scores on 
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this measure signify the range in patient social problem-solving abilities, from being 
extremely maladaptive to extremely adaptive, with most scores falling in the middle of the 
distribution.  
5.3.2 Initial Associations 
 Bivariate correlations were conducted to examine initial relationships among 
variables. In existent literature, covariates for asthma medication adherence included sex, 
age, education, income, employment status, marital status and parental asthma (Rod, 
Kristensen, Lange, Prescott, & Diderichsen, 2012). These demographic variables were not 
significantly correlated with the outcome measure (i.e., medication adherence based on 
pharmacy refills), indicating that there was no need to control for these variables in the main 
analyses. However, race/ethnicity was significantly correlated with all of the primary 
variables. As a result, it was included as a covariate in the analyses. Initial associations were 
also evaluated to rule out potential issues of multicollinearity, which occurs when there is a 
strong correlation between two or more predictors, making it difficult to assess the 
individual importance of each predictor (Field, 2013). None of the primary variables were 
highly correlated (above .7), therefore all primary variables were included in the main 
analyses. It is interesting to note that despite the literature reporting significant differences 
between subjective and objective reports of adherence (Krishnan et al., 2012), self-report 
and pharmacy refill adherence were positively correlated in this study (see Table 4). There 
was also a positive association between both measures of asthma control, suggesting that 
these research participants were relatively accurate in assessing control of their asthma.  
However, both variables were included in the model given their moderate correlation and 
lack of multicollinearity.  
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5.4 Main Analyses 
  
5.4.1 Hypothesis 1 
 
 Hypothesis one was partially confirmed. It was hypothesized that bivariate 
correlation analyses would demonstrate significant associations between all dimensions of 
social problem-solving (NPO, PPO, RPS, ICS, AS) with asthma control (ACT), perceived 
control of asthma (PCAQ), perceived stress (PSS) and pharmacy reports of medication 
adherence.  
 Hypothesis one employed Pearson product-moment correlations to examine 
relationships between primary variables (see Table 4). In line with the hypothesis, 
dysfunctional dimensions of social problem-solving (NPO, ICS, AS) were positively 
associated with perceived stress. This finding is in line with prior literature because those 
with more maladaptive social problem-solving tend to report higher levels of perceived 
stress (Nezu et al., 2013). Also, perceived stress was negatively correlated with positive 
problem orientation (PPO) and total social problem-solving scores, suggesting that 
individuals with more adaptive problem-solving tendencies reported lower levels of stress. 
Stress was also negatively correlated with self-report medication adherence. In other words, 
individuals who reported higher levels of adherence also reported lower levels of stress. 
Both assessments of asthma control were negatively correlated with stress, suggesting that 
higher levels of objective and perceived control of asthma are associated with less perceived 
stress. Additionally, all three dysfunctional dimensions of social problem-solving were 
negatively correlated with perceived control of asthma. Individuals with maladaptive social 
problem-solving tendencies reported lower perceived control of asthma, meaning that they 
were less likely to be coping effectively with their asthma and less likely to feel in control of 
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their asthma. Two of the dysfunctional dimensions (NPO and AS) were negatively 
correlated with objective asthma control. These findings mean that individuals with more 
maladaptive social problem-solving tendencies were more likely to have poorly controlled 
asthma characterized by increased use of rescue inhaler and functional impairments like 
waking up at night or being unable to get as much done at work, school or home. 
Unexpectedly, higher pharmacy reported rates of adherence (i.e., more refills) was 
associated with decreased perceived control of asthma. In other words, patients who do not 
feel in control of their asthma were likely to refill their inhalers more often. This relationship 
could mean that patients do not feel like they have internalized the abilities or skills to 
manage their asthma.  Therefore, they may believe that they need medications and additional 
outside resources to cope with their chronic illness. Regarding self-report adherence, low 
adherence was associated with higher scores on all three dysfunctional dimensions of social 
problem-solving and higher adherence was associated with higher total social problem-
solving scores. These results are also in line with the hypothesis and suggest that individuals 
with more maladaptive social problem-solving tendencies report lower levels of adherence, 
while more adaptive problem-solvers tend to report higher levels of adherence.  
 Together, these findings add valuable information to the current literature. First, 
more maladaptive social problem-solving tendencies are associated with higher levels of 
perceived stress, lower perceived control of asthma, lower objective asthma control and 
lower self-reports of asthma medication adherence. These results suggest that improvements 
in the dysfunctional domains of problem-solving might help decrease levels of stress and 
improve asthma management. Specifically, interventions aimed at improving social-problem 
solving abilities may help increase perceived and objective asthma control and improve 
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medication adherence. Improvements in perceived control of asthma can decrease feelings 
of learned helplessness and help patients feel more in control of their chronic condition, 
while improvements in objective control would help patients be more productive on a daily 
basis by decreasing functional impairment from asthma. In addition, efforts to decrease 
stress in asthma patients could also lead to improvements in social problem-solving and 
asthma management. Targeting levels of perceived stress may help facilitate patient 
perceived control of their asthma, reduce daily limitations associated with their symptoms, 
and increase rates of medication adherence.  
5.4.2 Hypothesis 2 
 
 Hypothesis two was partially confirmed. It was hypothesized that social problem-
solving, asthma control, perceived asthma control and perceived stress would all 
significantly predict pharmacy reports of medication adherence. 
 Hypothesis two employed a hierarchical regression analysis to determine which 
variables would emerge as significant predictors of medication adherence in asthma patients, 
based on pharmacy refill history. The overall model was significant, meaning that these 
primary variables did account for a significant proportion of variance in the outcome of 
medication adherence. However, perceived control of asthma was the only variable 
significantly predicted medication adherence, when controlling for race/ethnicity. This 
means that perceived control of asthma was explaining a significant amount of variation in 
pharmacy reports of medication adherence. Specifically, lower levels of perceived control of 
asthma predicted higher pharmacy reports of adherence. As previously stated, the direction 
of this association between perceived control of asthma and pharmacy refills is surprising. 
Initially, it was hypothesized that higher perceived control of asthma would lead to better 
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adherence but the contrary seems to be true. This finding makes more sense after further 
examination of the specific perceived control of asthma measure. Participants were asked to 
agree or disagree with statements such as, “I can do a lot of things myself to cope with my 
asthma, I can reduce my asthma by staying calm and relaxed, and I have considerable ability 
to control my asthma.” Patients scoring high on this measure are more likely to believe that 
they do not need resources other than themselves to successfully manage their asthma. 
Patients scoring low on this measure are more likely to rely on physicians and medications 
since they have lower self-efficacy and do not believe they are capable of managing their 
asthma on their own.  
 This noteworthy finding adds important information to the current understanding of 
perceived control of asthma and medication adherence. While research has documented the 
importance of patients feeling in control of their asthma (Katz et al. 2002; Taitel, Allen, & 
Creer, 1998; van der Palen, Klein, & Seydel, 1997), it is of utmost importance for patients to 
adhere to their daily inhaler use. It is possible that patients are overconfident in their abilities 
to manage their asthma, leading to beliefs that they do not need their medications. It may be 
important for physicians to increase patient awareness of the benefits of daily inhaler use 
and to stress the detrimental effects of poor adherence. In fact, increased medical knowledge 
and psychoeducation may be especially important for patients with higher perceived control 
of asthma. 
5.4.3 Hypothesis 3 
 
 Hypothesis 3 was not confirmed. It was hypothesized that social problem-solving 
would modify (i.e., strengthen, weaken, change the direction) the relationship between stress 
and medication adherence. Social problem-solving did not significantly interact with stress 
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to predict pharmacy reports of medication adherence. The lack of significance within this 
analysis may be attributable to the low sample size for pharmacy reports of adherence. In 
accordance with the literature, limitations in assessment of this variable include the fact that 
many patients use home delivery pharmacy companies, multiple different pharmacies, 
frequently change their inhaled corticosteroid prescriptions, obtain samples from physicians, 
or intentionally decrease the dosage of medications when not experiencing symptoms (i.e., 
only using inhalers seasonally when allergy symptoms are increased). These findings stress 
the importance of obtaining reliable, objective assessments of medication adherence for 
asthma controller medications.   
5.5 Exploratory Analyses 
 
 Exploratory analyses were conducted to evaluate the relationships between primary 
variables and perceived stress in asthma patients. Research has documented a strong link 
between psychological stress and asthma symptoms (Rand, Wright, Cabana, Foggs, 
Halterman, Olson, Vollmer, Wilson & Taggart, 2012; Rietveld, Everaerd, & Creer, 2000). 
Interpreting associations between stress and asthma might aid in the development of 
integrative treatment plans for patients with asthma that could improve self-management 
skills.  
  A hierarchical regression analysis was conducted to identify which of the primary 
variables significantly predict stress in patients with asthma. Due to the limited sample size 
of pharmacy refill as the adherence measure, the self-report assessment of adherence was 
used for this analysis. Additionally, race/ethnicity and income were both controlled for in 
this regression analysis given their significant correlation with perceived stress. Results of 
the analysis indicated that self-report medication adherence was a significant predictor of 
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perceived stress, when controlling for demographic variables. In particular, it was found that 
participants who reported lower adherence rates also reported higher levels of perceived 
stress. This finding is in line with current research, such that higher levels of stress are 
associated with poor adherence in individuals with asthma (Rand et al., 2012; Wright et al., 
1998). Additionally, patients with lower levels of perceived control of asthma also reported 
higher stress. This finding is expected because a lack of confidence and self-efficacy in the 
management of a chronic illness has been associated with higher levels of stress. 
Furthermore, this analysis provided evidence that poorer social problem-solving abilities 
were associated with increased stress, even when controlling for variance explained by 
demographic factors and the additional primary variables. This finding highlights the 
important relationship between social problem-solving and stress. Further, it provides 
evidence that interventions aimed at improving social problem-solving abilities may help 
reduce stress in patients with asthma.  
 Exploratory analyses of variance (ANOVAs) were also run to examine racial/ethnic 
differences in psychological factors of asthma management. Results revealed differences 
among individuals who identify as White, Black/African-American and Other on every 
primary variable. Specifically, individuals who identify as White reported greater self-report 
adherence, less perceived stress, better social problem-solving abilities, higher perceived 
control of asthma, and better objective control of asthma, as compared to other racial and 
ethnic groups. These findings support extant literature and demonstrate the racial and ethnic 
disparities among patients with asthma (CDC, 2004). They also highlight the importance of 
recognizing that psychosocial treatment effectiveness may need to be adapted based on 
racial or ethnic identity. Tailored treatments and special considerations for racial and ethnic 
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minorities must be taken into account when designing and implementing treatment plans for 
diverse groups of patients. 
5.6 Clinical Implications 
 
 Relatively few studies have examined psychosocial factors among asthma patients 
and even fewer have examined psychological factors of asthma management. Distress and 
poor psychosocial adjustment is common among individuals with chronic illnesses. Asthma 
in particular is typically characterized by poor self-management techniques, such as 
nonadherence to prescribed medication regimens and low levels of asthma control, both 
perceived and objective (Chapman et al., 2008). Poor asthma management has led to 
extreme increases in the cost of asthma as a chronic disease (i.e., hospitalizations, 
emergency room visits, missed work) (Healthcare Cost and Utilization Project, 2015). The 
current study identified psychological factors that may help improve asthma management 
and eventually decrease overall economic burden of asthma as a chronic illness.   
Medication adherence is a crucial facet of asthma management and has been 
documented to be extremely poor (Windsor et al., 1990). This study is among few to look at 
two outcome measures of adherence, both objective and subjective. Patients and physicians 
both tend to overestimate the frequency that patients take their prescribed medications, 
which is why it is imperative to include a reliable objective report. Research supports the 
notion that a multi-method approach is necessary for assessing true adherence rates 
(Krishnan et al., 2012). While objective measures tend to be difficult to employ, this study 
was able to obtain pharmacy refill information on inhaled corticosteroids for most 
participants. In addition, examining the differences between subjective and objective data 
has important clinical implications for understanding whether this disparity exists. Despite 
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prior research observing differences between self-report and objective measures, the 
adherence measures in this study were positively correlated, showing that there was 
accordance between both assessment techniques.  
This study is also among few to assess two measures of asthma control, both 
perceived control of asthma and objective asthma control, which are two constructs for 
understanding asthma management. Asthma control has been identified as the most 
important measure of overall asthma health (CDC, 2015). Additionally, psychological 
factors of self-efficacy, locus of control and learned helplessness, which were assessed 
through the perceived control of asthma measure, have been shown to have an impact on 
asthma exacerbations and management techniques (Katz et al. 2002). This study compared 
assessments of asthma control to determine how patient perception of psychological factors 
match up to their objective asthma control. Comparisons of these assessments are clinically 
important in developing psychosocial interventions that seek to teach patients how to 
identify actual asthma control and maximize perceived and actual control over their illness.  
Identifying associations among asthma management factors and psychological 
factors such as social problem-solving and perceived stress are important first steps toward 
developing integrative treatment approaches (i.e., medical, psychological, and social) for 
patients with asthma. This research study identified important relationships among the 
dysfunctional dimensions of social problem-solving with higher perceived stress, lower 
perceived and objective control of asthma and lower self-report medication adherence rates. 
These results highlight the important role that adaptive social problem-solving abilities can 
have on decreased perceived stress and increased asthma control and medication adherence. 
Incorporating stress management into treatment for asthmatics may improve patient 
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perception of asthma control, objective asthma control and adherence rates. Increases in all 
these components of asthma management should ultimately lead to decreases in asthma 
exacerbations, hospitalizations and emergency room visits. Furthermore, decreased stress 
and increased social problem-solving abilities will hopefully lead to better psychosocial 
adjustment for patients with asthma.  
In addition to advancing knowledge in this field, the results have meaningful clinical 
implications. The findings emphasize the importance of patient education regarding daily 
inhaler use. Contrary to what was hypothesized, participants who reported lower perceived 
control of asthma were more likely to refill their inhaled corticosteroids than participants 
reporting higher perceived control. Ratings of perceived control of asthma fall along the 
range from being entirely internal and believing that asthma is in one’s own hands to being 
entirely external and believing that fate and other factors are in control of asthma. Previous 
research indicates that low perceived control of asthma is associated with increased asthma 
exacerbations and poor self-management techniques (Katz et al., 2002). However, the 
current findings suggest that patients with low perceived control are more likely to fill their 
asthma medications, possibly because they have an external locus of control and low self-
efficacy surrounding their asthma. Such participants are more likely to rely on external 
factors (i.e., physicians, medications) to control their asthma. The present study suggests that 
anticipation of the degree of control individuals have over their illness does influence their 
motivation to engage in self-management behaviors. Specifically, individuals in this study 
who experienced low sense of control over their asthma may have had increased motivation 
to use their medications. These results have important implications for clinical practice since 
the ultimate goal is achieving both optimal asthma control and optimal adherence rates. 
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Treatment plans for asthma patients should incorporate psychoeducation and skill trainings, 
such as social problem-solving abilities, behavioral stress techniques, as well as practical 
medical education, for instance, the physical importance of daily inhaler use. The inclusion 
of these skills and techniques are likely to increase perceived control of asthma, actual 
control over asthma symptoms, and medication adherence.  
Results also identify factors that are predictive of perceived stress in patients with an 
asthma diagnosis. Previous research provides evidence that stress plays a major role in 
asthma as a chronic condition, specifically showing links between high stress and increased 
hospitalizations along with poor self-management skills (Rand et al., 2012; Rod et al., 
2012). Findings from the current study identify lower self-report adherence, lower perceived 
control of asthma, and poorer social problem-solving abilities as predictors of higher 
perceived stress. Impairments in social problem-solving abilities are associated with 
difficulties coping with chronic illness (Doorenbos et al., 2005; Kerns et al., 2002), which 
may be attributable to higher perceived stress in these patients. It is also possible that social 
problem-solving may be able to increase medication adherence by facilitating reductions in 
stress. Targeting these factors through integrative treatment approaches, healthcare providers 
may be able to decrease stress and improve overall psychosocial functioning in asthma 
patients.  
Finally, this study identifies racial and ethnic disparities among psychological and 
self-management factors related to asthma. Notably, asthma does affects racial and ethnic 
groups differently. According to the CDC, asthma prevalence, morbidity, and mortality are 
all higher among certain racial/ethnic minority populations than among individuals who 
identify as White (2004). Black/African American and Hispanic/Latino asthma patients 
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report more emergency department visits, lifetime hospitalizations, severe acute 
exacerbations, and are less likely to use inhaled corticosteroids (Boudreaux, Emond, Clark, 
& Camargo, 2003). In addition, research has outlined evidence that the factors associated 
with ICS adherence differ greatly between patients who identify as White and those who 
identify as Black/African American (Wells, Pladevall, Peterson, Campbell, Wang, Lanfear, 
& Williams, 2008). Prior research, however, has mainly focused on racial and ethnic 
disparities among children and adolescents with asthma (Akinbami, Moorman, Simon, & 
Schoendorf, 2014), and has yet to explore detailed disparities among psychological 
outcomes in patients with asthma. Findings from this study highlight the importance of 
tailoring interventions aimed at improving psychosocial adjustment to racial and ethnic 
minority groups to improve adherence and overall psychosocial adjustment among all 
patients with asthma.  
5.7 Limitations and Future Directions 
 
 The current study had several limitations that may constrain the generalizability of 
the results. While this study included a multi-method approach to assessing medication 
adherence, the distributions for both self-report and pharmacy refills may have been skewed. 
The pharmacy reports of adherence were difficult to obtain for a variety of reasons. First, 
many patients use home delivery pharmacies (i.e., Express Scripts, Prime Mail, Optum Rx), 
and pharmacy refill information from these pharmacies was not accessible and therefore 
analyses including this variable were slightly underpowered. Refill data may have been 
influenced by the fact that some patients refill their medications at multiple different 
pharmacies and information on only one pharmacy was obtained for each participant. This 
resulted in many pharmacies having very little refill information for patients since they may 
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have been switching from one pharmacy to another. Additionally, patients tended to switch 
inhaled corticosteroid inhalers based on what is covered by their insurance and on their 
preference for a specific type of inhaler. In this study, information about previous inhaler 
use was not recorded, resulting in less refill information for patients who may have been on 
multiple different inhalers within the past year. Furthermore, some of the patients in the 
study verbally reported that they only use their inhalers seasonally (i.e., when the weather is 
cold, during allergy season). Future researchers should ask patients if they use their inhalers 
year-round or if they alter the dosage either on their own or based on physician 
recommendations. Finally, information regarding sample inhalers was not collected. Many 
times, physicians will provide patients with samples of inhalers that may not be covered by 
their insurance or to get them started on an inhaler immediately before being required to 
pick up a prescription. This data was not collected, which suggest that pharmacy refill 
reports may have been lower than actual inhaler use.  
Limitations also exist within the self-report medication adherence measure that was 
used. Many participants in this study expressed confusion while completing the self-report 
adherence measure, due to the awkward wording of some of the phrases. Further, 
participants may have been over-reporting adherence since they were completing these 
measures while in a physician exam room and with a researcher present. Moreover, this self-
report measure does not assess levels of unintentional nonadherence, such as patients not 
realizing that they are being non-adherent (i.e., forgetfulness, confusion about dosage). 
Future research should focus on developing and utilizing more reliable assessments of 
adherence, both self-report and objective measures. If adequate resources are available, 
objective adherence methods such as electronic device monitors for inhalers or obtaining 
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information from insurance companies regarding all medication refills should be used. In 
terms of medication adherence, future researchers should also attempt to collect information 
regarding inhaler technique. While it may objectively look like a patient is taking their 
medication, they may have poor inhaler technique (i.e., inhaling too rapidly, failing to hold 
breath after inhaler use, actuating inhaler too early or too late), which can serve as a 
confounding variable for objective adherence measures.  
In terms of asthma control, limitations likely exist due to the ceiling effect of the 
asthma control test results. Many patients in this study reported perfectly controlled asthma 
and given the familiarity of the assessment with routine check-in with physicians, they may 
be in the habit of over-reporting their asthma control. There is also evidence that patients’ 
self-report of asthma control is not always accurate. According to the guidelines by the 
National Asthma Education and Prevention Program (NAEPP), despite high rates of rescue 
inhaler use, urgent care visits, and emergency room visits, patients tend to rate their asthma 
as more well controlled than they should (Murphy, Meltzer, Blaiss, Nathan, Stoloff, & 
Doherty, 2012). These findings speak to the need for more accurate ways to identify 
objective asthma control and teach patients to more effectively identify poorly controlled 
asthma. For future studies, it would be useful to examine if patients with higher perceived 
control of asthma have fewer asthma exacerbations, even if they are less adherent. It is 
possible that these patients do not use their medication as often because they are actually 
better able to manage the physiological aspects of asthma through improved stress and 
coping skills. Future studies should consider incorporating physiological assessments to 
determine actual versus perceived inflammation along with objective and perceived asthma 
control measures. In terms of asthma control, it would also be interesting to include 
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information on when a patient received his or her asthma diagnosis. A patient who was 
diagnosed in childhood may have a vastly different experience with their asthma diagnosis 
as compared to someone who was more recently diagnosed in adulthood.   
 Another limitation of the present study is the self-report, cross-sectional research 
design. The self-report nature of the study increased the likelihood of response bias and 
social desirability, which is likely what occurred with the asthma control test and the self-
report adherence scale. Participants may have been attempting to display themselves in a 
positive light by reporting perfect adherence and perfectly controlled asthma. Likewise, the 
fact that the study survey completion was done at the physician’s office may have also 
increased biases. Future studies should attempt to incorporate more methods within the 
multi-method approach to data collection in an effort to supplement self-report data. For 
example, obtaining information from physicians on their perceptions of patients’ asthma 
control and psychosocial adjustment, along with including qualitative responses could lead 
to a better understanding of the patient’s medical and psychological experience of their 
asthma.  
The fact that the assessments were completed in-person could have also served as a 
limitation for this study. Aside from facilitating social desirability bias, the in-person nature 
prevented many patients from participating in the study due to time restraints. Future 
research might offer an online option for research participation so that patients can complete 
the questionnaires on their own time, in a comfortable environment. Participation in the 
study was also only available to patients at one of two outpatient physician practices. An 
online option could include a wide range of asthma patients with diverse backgrounds and 
from a variety of sites throughout the country. It would also be helpful to collect data from 
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patients at an inpatient setting who may be experiencing more severe, acute asthma 
exacerbation. In addition, participation in this study was limited to patients seeing a 
respiratory specialist (i.e., pulmonologist, allergist) in an outpatient setting, and a majority of 
these patients had well-controlled asthma at the time of their routine follow-up visit. 
Specialists tend to have a better perception of patient asthma control, while general 
practitioners tend to overestimate asthma control in their patients. In addition, research 
suggests that specialists implement asthma management plans and recommendations more 
often than any other physicians (i.e., family practitioners, internists) (Murphy et al., 2012). 
These differences in practitioners could be another explanation for high rates of asthma 
control in this sample and underline how important it is for asthmatics to see a specialist 
who will implement asthma management recommendations to improve asthma outcomes.  
 Future research should seek to include a more racially/ethnically diverse sample. In 
the current sample, most research participants identified as White or Black/African-
American, leaving a very small sample size of other racial and ethnic minorities. There is a 
large amount of variability in this “other” group, so future studies should attempt to look at 
specific differences among all racial and ethnic groups. While this research study highlights 
differences in the outcome variables as a function of race and ethnicity, research has not yet 
identified why such disparities are occurring. Some extant work suggests that racial and 
ethnic differences are a result of genetic variations along with differing environmental 
exposures, socio-economic status, adverse childhood experiences, and psychological and 
cultural differences among ethnic groups (Forno, & Celedón, 2009), but attempts to fully 
address these discrepancies have not yet been successful. These findings are clinically 
important because they highlight the need for specified treatments and varying needs of 
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diverse racial and ethnic groups. Future research and publications should attempt to look at 
differences by site and should control for socioeconomic status when analyzing racial and 
ethnic disparities. While racial and ethnic differences were found in this study, there are 
confounding variables (i.e., setting, employment status, socioeconomic status) that may also 
explain such disparities.  
5.8 Summary and Conclusion 
 
 Asthma is a serious public health concern with its increasing prevalence and 
increasing economic burden over the last decade. In addition to the physical limitations that 
patients with asthma struggle with, psychosocial adjustment to the chronic illness remain 
challenging. Understanding the factors that impact adjustment and outcomes for asthma 
patients is critical for improving and implementing psychosocial support and integrative 
treatment modalities. The current study highlights the importance of the role of social 
problem-solving and perceived stress in the evaluation of asthma management. Specifically, 
individuals with more adaptive social problem-solving tendencies report less stress, higher 
perceived control of asthma, better objective asthma control, and higher self-report 
medication adherence. Results also indicate that higher stress in asthma patients is 
associated with lower self-report adherence, and that more adaptive social problem-solving 
abilities and higher perceived control of asthma are predictive of less perceived stress. This 
research study also identifies differences in asthma management and psychological factors 
as a function of race/ethnicity. Overall, results suggest that further research examining 
psychosocial factors that are predictive of medication adherence as well as more effective 
ways to assess adherence is warranted. Psychosocial interventions that include medical 
education need to be developed and integrated in treatment plans for patients with asthma. 
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These interventions should focus on the improvement of self-management skills, such as 
asthma control, perceived control, and adherence, as well as behavioral stress techniques and 
coping skills to manage perceived stress. Research should aim to recruit more diverse 
samples to further examine discrepancies in asthma maintenance and psychosocial 
adjustment among patients of varying racial and ethnic backgrounds. Future studies should 
also consider utilizing a multi-method assessment approach, including information from 
physicians, pharmacies, and physiological measures to accurately assess adherence. 
Integration of these approaches will help asthma patients manage their chronic illness 
physically and psychologically by providing them with the resources and support that they 
need and deserve. 
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Table 1 
 
Table 1. Participant Demographic Variables 
 Total (N = 104) Drexel Pulmonary 
(n = 64) 
Atlantic Research 
Center (n = 40) 
Sex n (%) n (%) n (%) 
 Male 26 (25.0%) 17 (26.6%) 9 (22.5%) 
 Female 78 (75.0%) 47 (73.4%) 31 (77.5%) 
Race/ Ethnicity    
 White 51 (49.0%) 17 (26.6%) 34 (85.0%) 
 Black/ African American 39 (37.5%) 35 (54.7%) 4 (10.0%) 
 American Indian/ Alaska Native 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Asian 2 (1.9%) 1 (1.6%) 1 (2.5%) 
 Native Hawaiian/ Pacific Islander 1 (1.0%) 1 (1.6%) 0 (0.0%) 
 Hispanic/ Latino 7 (6.7%) 6 (9.4%) 1 (2.5%) 
 Multiracial 3 (2.9%) 3 (4.7%) 0 (0.0%) 
 Other 1 (1.0%) 1 (1.6%) 0 (0.0%) 
Relationship Status    
 Married/ Living with a partner 51 (49.0%) 25 (39.1%) 26 (65.0%) 
 Divorced/ Separated 13 (12.5%) 11 (17.2%) 2 (5.0%) 
 Widowed 8 (7.7%) 5 (7.8%) 3 (7.5%) 
 Single/ Never married 32 (30.8%) 23 (35.9%) 9 (22.5%) 
Children    
 Yes 75 (72.1%) 48 (75.0%) 27 (67.5%) 
 No 29 (27.9%) 16 (25.0%) 13 (32.5%) 
Education    
 Some elementary education 1 (1.0%) 1 (1.6%) 0 (0.0%) 
 Some high school 10 (9.6%) 8 (12.5%) 2 (5.0%) 
 High school diploma 25 (24.0%) 23 (35.9%) 2 (5.0%) 
 Some college 21 (20.2%) 12 (18.8%) 9 (22.5%) 
 College degree 32 (30.8%) 15 (23.4%) 17 (42.5%) 
 Graduate degree 15 (14.4%) 5 (7.8%) 10 (25.0%) 
Estimated Household Income    
 < $20,000 30 (28.8%) 27 (42.2%) 3 (7.5%) 
 $20,000 - $40,000 16 (15.4%) 14 (21.9%) 2 (5.0%) 
 $40,000 - $60,000 5 (4.8%) 4 (7.8%) 0 (0.0%) 
 $60,000 - $80,000 5 (4.8%) 1 (1.6%) 4 (10.0%) 
 $80,000 - $100,000 16 (15.4%) 6 (9.4%) 10 (25.0%) 
 > $100,000 28 (26.9%) 8 (12.5%) 20 (50.0%) 
 Not reported 4 (3.8%) 3 (4.7%) 1 (2.5%) 
Employment    
 Working full-time 35 (33.7%) 11 (17.2%) 24 (60.0%) 
 Working part-time 11 (10.6%) 6 (9.4%) 5 (12.5%) 
 Unemployed, seeking work 7 (6.7%) 6 (9.4%) 1 (2.5%) 
 Disabled/ unable to work 29 (27.9%) 27 (42.2%) 2 (5.0%) 
 Volunteer 1 (1.0%) 1 (1.6%) 0 (0.0%) 
 Retired  16 (15.4%) 11 (17.2%) 5 (12.5%) 
 Student 5 (4.8%) 2 (3.1%) 3 (7.5%) 
Sexual Orientation    
 Heterosexual 95 (91.3%) 58 (90.6%) 37 (92.5%) 
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 Homosexual (Gay/ lesbian) 3 (2.9%) 2 (3.1%) 1 (2.5%) 
 Bisexual 3 (2.9%) 2 (3.1%) 1 (2.5%) 
 Other 1 (1.0%) 1 (1.6%) 0 (0.0%) 
 Not reported 2 (1.9%) 1 (1.6%) 1 (2.5%) 
Religious Identity    
 Agnostic 3 (2.9%) 0 (0.0%) 3 (7.5%) 
 Atheist 4 (3.8%) 3 (4.7%) 1 (2.5%) 
 Buddhist 3 (2.9%) 2 (3.1%) 1 (2.5%) 
 Catholic 35 (33.7%) 14 (21.9%) 21 (52.5%) 
 Christian 32 (30.8%) 29 (45.3%) 3 (7.5%) 
 Jewish 6 (5.8%) 2 (3.1%) 4 (10.0%) 
 Hindu 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Mormon 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Muslim 2 (1.9%) 2 (3.1%) 0 (0.0%) 
 Not affiliated, but religious/ spiritual 6 (5.8%) 4 (6.3%) 2 (5.0%) 
 No religious/ spiritual identity 7 (6.7%) 5 (7.8%) 2 (5.0%) 
 Other 5 (4.8%) 3 (4.7%) 2 (0.0%) 
 Not reported 1 (1.0%) 0 (0.0%) 1 (2.5%) 
Religiosity    
 Not at all religious 21 (20.2%) 11 (17.2%) 10 (25.0%) 
 Somewhat religious 55 (52.9%) 30 (46.9%) 25 (62.5%) 
 Very religious 27 (26.0%) 22 (34.4%) 5 (12.5%) 
 Not reported 1 (1.0%) 1 (1.6%) 0 (0.0%) 
Health Insurance    
 Private plan (employment-based) 49 (47.1%) 16 (25.0%) 33 (82.5%) 
 Private plan (direct-purchase) 3 (2.9%) 2 (3.1%) 1 (2.5%) 
 Medicare 41 (39.4%) 35 (54.7%) 6 (15.0%) 
 Medicaid 8 (7.7%) 8 (12.5%) 0 (0.0%) 
 Military health care 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Uninsured 1 (1.0%) 1 (1.6%) 0 (0.0%) 
 Not reported 1 (1.0%) 1 (1.6%) 0 (0.0%) 
 M ± SD Range M ± SD Range M ± SD Range 
Patient Age 51.85 ± 
15.77 
18 – 78 53.98 ± 
14.73 
19 – 77  48.50 ± 
16.95 
18 – 78  
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Table 2 
 
Table 2. Participant Health/ Medical Record Demographics  
 Total (N = 104) Drexel Pulmonary 
(n = 64) 
Atlantic Research 
Center (n = 40) 
Smoking Status n (%) n (%) n (%) 
 Current smoker (daily) 3 (2.9%) 3 (4.7%) 0 (0.0%) 
 Current smoker (occasionally) 1 (1.0%) 0 (0.0%) 1 (2.5%) 
 Past smoker 27 (26.0%) 22 (34.4%) 5 (12.5%) 
 Never smoked/ used tobacco products 73 (70.2%) 39 (60.9%) 34 (85.0%) 
Alcohol Use    
 Never 48 (46.2%) 38 (59.4%) 10 (25.0%) 
 0-3 days/ month 28 (26.9%) 16 (25.0%) 12 (30.0%) 
 1 day/ week 9 (8.7%) 4 (6.3%) 5 (12.5%) 
 2 days/ week 7 (6.7%) 2 (3.1%) 5 (12.5%) 
 3 days/ week 4 (3.8%) 2 (3.1%) 2 (5.0%) 
 4 days/ week 4 (3.8%) 1 (1.6%) 3 (7.5%) 
 5 days/ week 1 (1.0%) 0 (0.0%) 1 (2.5%) 
 6 days/ week 1 (1.0%) 1 (1.6%) 0 (0.0%) 
 7 days/ week 2 (1.9%) 0 (0.0%) 2 (5.0%) 
Physical Activity    
 Sedentary, inactive 11 (10.6%) 10 (15.6%) 1 (2.5%) 
 Seldom active 20 (19.2%) 14 (21.9%) 6 (15.0%) 
 Moderately active 64 (61.5%) 37 (57.8%) 27 (67.5%) 
 Vigorously active 8 (7.7%) 2 (3.1%) 6 (15.0%) 
 Not reported 1 (1.0%) 1 (1.6%) 0 (0.0%) 
Presence of Mental Health Diagnosis    
 Yes 24 (23.1%) 16 (25.0%) 8 (20.0%) 
 No 79 (76.0%) 48 (75.0%) 31 (77.5%) 
 Not reported 1 (1.0%) 0 (0.0%) 1 (2.5%) 
Past psychological treatment    
 None 62 (59.6%) 40 (62.5%) 21 (52.5%) 
 Individual therapy 21 (20.2%) 14 (21.9%) 7 (17.5%) 
 Group therapy 1 (1.0%) 1 (1.6%) 0 (0.0%) 
 Couple’s therapy 3 (2.9%) 1 (1.6%) 2 (5.0%) 
 Family therapy 1 (1.0%) 0 (0.0%) 1 (2.5%) 
 Medication 2 (1.9%) 1 (1.6%) 1 (2.5%) 
 More than 2 of the above 14 (13.5%) 7 (10.9%) 7 (17.5%) 
Current psychological treatment    
 None 84 (80.8%) 50 (78.1%) 34 (85.0%) 
 Individual therapy 12 (11.5%) 9 (14.1%) 3 (7.5%) 
 Group therapy 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Couple’s therapy 1 (1.0%) 1 (1.6%) 0 (0.0%) 
 Family therapy 2 (1.9%) 1 (1.6%) 1 (2.5%) 
 Medication 3 (2.9%) 1 (1.6%) 2 (5.0%) 
 More than 2 of the above 2 (1.9%) 2 (3.1%) 0 (0.0%) 
Parental Asthma    
 Mother 19 (18.3%) 12 (18.8%) 7 (17.5%) 
 Father 13 (12.5%) 11 (17.2%) 2 (5.0%) 
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 Both 1 (1.0%) 1 (1.6%) 0 (0.0%) 
 Don’t know 17 (16.3%) 13 (20.3%) 4 (10.0%) 
 Neither 54 (51.9%) 27 (42.2%) 27 (67.5%) 
Ever been hospitalized for asthma    
 Yes 47 (45.2%) 36 (56.3%) 11 (27.5%) 
 No 57 (54.8%) 28 (43.8%) 29 (72.5%) 
Been hospitalized in the past year    
 Yes 18 (17.3%) 16 (25.0%) 2 (5.0%) 
 No 86 (82.7%) 48 (75.0%) 38 (95.0%) 
Ever visited the ER for asthma    
 Yes 55 (52.9%) 41 (64.1%) 14 (35.0%) 
 No 49 (47.1%) 23 (35.9%) 26 (65.0%) 
Been to the ER in the past year    
 Yes 32 (30.8%) 26 (40.6%) 6 (15.0%) 
 No 72 (69.2%) 38 (59.4%) 34 (85.0%) 
Ever been intubated    
 Yes 11 (10.6%) 9 (14.1%) 2 (5.0%) 
 No 93 (89.4%) 55 (85.9%) 38 (95.0%) 
Been intubated in the past year    
 Yes 3 (2.9%) 3 (4.7%) 0 (0.0%) 
 No 101 (97.1%) 61 (95.3%) 40 (100%) 
Physician visits for asthma    
 Once per month 14 (13.5%) 13 (20.3%) 1 (2.5%) 
 Every 3 months 38 (36.5%) 27 (42.2%) 11 (27.5%) 
 Every 6 months 42 (40.4%) 21 (32.8%) 21 (52.5%) 
 Once per year 7 (6.7%) 1 (1.6%) 6 (15.0%) 
 Less than once per year 3 (2.9%) 2 (3.2%) 1 (2.5%) 
Asthma diagnosis    
 Mild persistent 14 (13.5%) 10 (15.6%) 4 (10.0%) 
 Moderate persistent 47 (45.2%) 24 (37.5%) 23 (57.5%) 
 Severe persistent 43 (41.3%) 30 (46.9%) 13 (32.5%) 
 
 
 
  
   58 
Table 3 
 
   Table 3. Total and Subscale Scores for Primary Variables  
 M ± SD Range 
Pharmacy Refill1 (N = 71)   0 – 12 
 Total Score 4.94 ± 4.06 0 – 12 
Asthma Control2 (N = 104)  5 – 25 
 Total Score 16.99 ± 6.01 5 – 25 
Perceived Asthma Control3 (N = 104)  11 – 55 
 Total Score 39.18 ± 8.48 17 – 55 
Self-Report Adherence4 (N = 104)  0 – 5  
 Total Score 4.23 ± 0.83 1.6 – 5  
Perceived Stress5 (N = 102)  0 – 56 
 Total Score 21.58 ± 8.02 3 – 46  
Social Problem-Solving6 (N = 103)  0 – 20  
 Total Score 13.95 ± 2.63 8.2 – 18.6 
 Positive Problem Orientation (PPO) 13.10 ± 4.74 0 – 20  
 Negative Problem Orientation (NPO) 5.05 ± 4.68 0 – 17  
 Rational/ Planful Style (RPS) 12.11 ± 4.55  0 – 20 
 Impulsive/ Careless Style (ICS) 5.38 ± 3.85  0 – 17  
 Avoidant Style (AS) 5.01 ± 4.51 0 – 18 
    Note. Higher pharmacy refill scores indicate better adherence. Higher asthma control scores indicate 
better asthma control. Higher perceived control of asthma scores indicate higher perceived control of 
asthma. Higher self-report adherence scores indicate better adherence. Higher perceived stress scores 
indicate more stress. Higher social problem-solving scores indicate more adaptive social problem-
solving tendencies.  
 
 
 
 
 
 
 
                                                
1 Pharmacy refill was assessed using the medication possession ratio (MPR). 
2 Asthma control was measured with Asthma Control Test (ACT). 
3 Perceived asthma control was measured with Perceived Control of Asthma Questionnaire (PCAQ). 
4 Self-report adherence was measured with Medication Adherence Report Scale for Asthma (MARS-
A). 
5 Perceived stress was measured with Perceived Stress Scale (PSS). 
6 Social Problem-Solving was measured with Social Problem-Solving Inventory-Revised: Short 
Form (SPSI-R:S). 
  
Table 4 
 
Table 4. Bivariate Correlations of Primary Study Variables  
Variable 1 2 3 4 5 6 7 8 9 10 11 
(1) Pharmacy Refill 
(MPR) 
__           
(2) Perceived Control 
(PCAQ) 
-.31** __          
(3) Asthma Control 
(ACT) 
-.12 .57** __         
(4) Perceived Stress 
(PSS) 
.00 -.40** -.21* __        
(5) Self-Report 
Adherence (MARS) 
.31** .13 .18 -.27** __       
(6) PPO (SPSI) 
 
.01 -.05 -.04 -.20* -.08 __      
(7) NPO (SPSI) 
 
-.21 -.22* -.22* .51** -.22* .05 __     
(8) RPS (SPSI) 
 
-.00 -.04 -.04 -.14 -.04 .69** .18 __    
(9) ICS (SPSI)  
 
-.16 -.20* -.18 .32** -.22* .14 .61** .16 __   
(10) AS (SPSI) 
 
-.14 -.23* -.26** .41** -.30** .04 .63** .17 .68** __  
(11) Social Problem-
Solving 
.18 .18 .19 -.53** .20* .53** -.67** .43** -.64** -.69** __ 
Note. *p < .05, **p < .01 
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Table 5 
 
  Table 4. Asthma Control, Stress and Social Problem-Solving Predicting Adherence  
Model 1 B Std. 
Error 
b t p 
 Race/ Ethnicity -.492 .257 -.225 -1.919 .059 
Model 2      
 Race/ Ethnicity -.568 .276 -.259 -2.059 .043 
 Perceived Stress .048 .063 .096 .762 .449 
Model 3      
 Race/ Ethnicity -.723 .277 -.331 -.2.615 .011 
 Perceived Stress -.029 .064 -.058 -.462 .646 
 Asthma Control -.036 .095 -.054 -.377 .708 
 Perceived Asthma Control -.186 .067 -.394 -2.792 .007 
Model 4      
 Race/ Ethnicity -.695 .274 -.318 -2.535 .014 
 Perceived Stress .028 .072 .055 .381 .704 
 Asthma Control -.047 .095 -.070 -.494 .623 
 Perceived Asthma Control -.178 .066 -.375 -2.683 .009 
 Social Problem-Solving .305 .191 .209 1.597 .115 
  Note. R2 = .051 (p = .059) for Model 1; ΔR2 = .008 (p = .449) for Model 2; ΔR2 = .145 (p < .01) for Model 3; 
ΔR2 = .030 (p = .115) for Model 4. The gray shading is used to indicate significant findings. 
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Table 6 
 
         Table 6. Adherence, Asthma Control, and Social Problem-Solving Predicting Perceived Stress 
Model 1 B Std. 
Error 
b t p 
 Race/ Ethnicity 1.342 .495 .287 2.710 .008 
 Income -.482 .403 -.126 -1.194 .235 
Model 2      
 Race/ Ethnicity 1.061 .501 .227 2.119 .037 
 Income -.488 .395 -.128 -1.235 .220 
 Medication Adherence -2.112 .936 -.220 -2.256 .026 
Model 3      
 Race/ Ethnicity .973 .486 .208 2.004 .048 
 Income -.299 .397 -.078 -.754 .453 
 Medication Adherence -1.907 .895 -.198 -2.131 .036 
 Asthma Control .203 .161 .148 1.259 .211 
 Perceived Asthma Control -.367 .104 -.386 -3.544 .001 
Model 4      
 Race/ Ethnicity .745 .426 .159 1.749 .084 
 Income .542 .379 .142 1.429 .156 
 Medication Adherence -1.066 .796 -.111 -1.339 .184 
 Asthma Control .132 .141 .096 .935 .352 
 Perceived Asthma Control -.354 .090 -.372 -3.912 .000 
 Social Problem-Solving -1.531 .280 -.494 -5.463 .000 
         Note. R2 = .129 (p < .01) for Model 1; ΔR2 = .045 (p < .05) for Model 2; ΔR2 = .101 (p < .01) for Model 3; 
ΔR2 = .179 (p < .001) for Model 4. The gray shading is used to indicate significant findings. 
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Table 7 
 
Table 7. ANOVA Displaying Differences in Primary Variables as a Function of Race/ Ethnicity 
Pharmacy Refill Adherence df Mean Square F p 
 Between Groups 2 31.030 1.933 .153 
 Within Groups 68 16.055   
 Total 70    
Self-Report Adherence     
 Between Groups 2 3.867 6.208 .003 
 Within Groups 101 .623   
 Total  103    
Perceived Stress     
 Between Groups 2 363.310 6.231 .003 
 Within groups 99 58.306   
 Total  101    
Social Problem-Solving     
 Between Groups 2 38.938 6.195 .003 
 Within Groups 100 6.285   
 Total 102    
Asthma Control     
 Between Groups 2 292.765 9.436 .000 
 Within Groups 101 31.027   
 Total 103    
Perceived Control of Asthma     
 Between Groups 2 278.458 4.062 .020 
 Within Groups 101 68.554   
 Total 103    
Note. The gray shading is used to indicate significant findings. 
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Table 8 
 
Table 8. Means and Standard Deviations of Outcomes as a Function of Race/ Ethnicity  
              M ± SD 
Outcome Variable White 
(n = 51)  
Black/ African 
American (n = 39) 
Other (n = 14) 
 Pharmacy Refill Adherence 5.71 ± 4.11 5.00 ± 4.24 3.00 ± 2.95 
 Self-Report Adherence 4.49 ± .737 4.08 ± .827 3.74 ± .865 
 Perceived Stress 20.20 ± 6.98 20.95 ± 8.20 28.21 ± 8.32 
 Social Problem-Solving 14.76 ± 2.20 13.52 ± 2.82 12.30 ± 2.63 
 Asthma Control 19.28 ± 5.89 15.44 ± 5.11 13.00 ± 5.60 
 Perceived Control of Asthma 41.43 ± 8.64 38.18 ± 8.05 34.86 ± 7.50 
Note. “Other” includes individuals who identify as American Indian/Alaska Native, Asian, Native 
Hawaiian/Pacific Islander, Hispanic/Latino and Multiracial.
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Appendix A: Measures 
 
Demographic Questionnaire 
 
1. How old are you?  ___________ 
 
2. What is your sex? 
o Male 
o Female 
 
3. How would you best describe your race/ ethnicity?
o White/ Caucasian 
o Black/ African American 
o American Indian/ Alaska Native 
o Asian 
o Native Hawaiian/ Pacific 
Islander 
o Hispanic/ Latino 
o Multiracial 
o Other 
 
4. What is your current relationship status?
o Married/ Living with a 
partner 
o Divorced/ Separated  
o Widowed 
o Single/ Never married
 
5. Do you have children? 
o Yes 
o If yes, how many children do you have?  ___________ 
o No 
 
6. What is the highest level of education that you have completed? 
¨ No Formal Education 
¨ Some Elementary Education 
¨ Some Middle School  
¨ Some High School  
¨ High School Diploma 
¨ Some College 
¨ College Degree 
¨ Graduate Degree 
 
7. What is your estimated household income?  (The combined income of all adults living in 
your household, including salaries and wages, retirement income, food stamps, and 
investment gains). Please remember that this information is confidential. 
o <$20,000 
o $20,000 - &40,000 
o $40,000 - $60,000 
o $60,000 - $80,000 
o $80,000 - $100,000 
o >$100,000 
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8. What is your current employment status? 
o Working full-time 
o Working part-time 
o Unemployed, seeking work 
o Disabled/ unable to work 
o Volunteer 
o Retired 
o Student 
 
9. How would you best describe your sexual orientation? 
¨ Heterosexual  
¨ Homosexual (Gay/ lesbian) 
¨ Bisexual 
¨ Other, please specify: ______________________________ 
 
10. What is your current religious identity? 
¨ Agnostic  
¨ Atheist 
¨ Buddhist 
¨ Catholic 
¨ Christian 
¨ Jewish 
¨ Hindu 
¨ Mormon 
¨ Muslim 
¨ Not affiliated, however, I am religious/ spiritual 
¨ No religious/ spiritual identity 
¨ Other, please specify: ________________________________ 
 
11. How religious do you consider yourself to be? 
¨ Not at all religious 
¨ Somewhat religious 
¨ Very religious 
 
12. What type of health insurance do you currently have? 
¨ Private plan (employment-based) 
¨ Private plan (direct-purchase) 
¨ Medicare 
¨ Medicaid 
¨ Military health care 
¨ Uninsured  
¨ Other 
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13. Smoking status: 
o Current smoker (daily) 
o Current smoker (occasional) 
o Past smoker 
o Never smoked or used tobacco products 
 
14. How often do you drink alcohol (any amount)? 
¨ Never 
¨ 0-3 days/ month 
¨ 1 day/ week 
¨ 2 days/ week 
¨ 3 days/ week 
¨ 4 days/ week 
¨ 5 days/ week 
¨ 6 days/ week 
¨ 7 days/ week 
 
15. On average, how many alcoholic drinks do you consume in a typical week? 
______________ 
 
16. How would you describe your level of physical activity? 
¨ Sedentary, inactive 
¨ Seldom active 
¨ Moderately active 
¨ Vigorously active  
 
17. Are you currently taking any medication (prescription or over the counter)? 
¨ Yes 
o If so, please list all current medications here: 
____________________________________________________ 
____________________________________________________ 
____________________________________________________ 
¨ No 
 
18.  How many prescription medications do you take on a daily basis? __________________ 
 
19. Have you ever suffered from or been diagnosed with any mental health problems (e.g., 
anxiety, depression, alcohol or drug abuse)? 
¨ Yes 
¨ No 
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20. Have you ever been in treatment for psychological or emotional distress? 
¨ Yes 
¨ No 
 
21. What type(s) of therapy have you tried in the past? (Check all that apply).  
¨ Individual therapy 
¨ Group therapy 
¨ Couple’s therapy 
¨ Family therapy 
¨ Medication for psychological/ emotional distress 
 
22. Are you currently in treatment for psychological or emotional distress? 
¨ Yes 
¨ No 
 
23. What type(s) of therapy are you currently using? (Check all that apply). 
¨ Individual therapy 
¨ Group therapy 
¨ Couple’s therapy 
¨ Family therapy 
¨ Medication for psychological/ emotional distress 
 
24. Have you ever been diagnosed with any of the following medical conditions? (Check all 
that apply) (To be scored using the Charlson Age-Comorbidity Index (CACI) calculator). 
 
o AIDS 
o Metastatic solid tumor 
o Moderate or severe liver 
disease 
o Any non-metastatic solid 
tumor 
o Malignant lymphoma 
o Leukemia  
o Diabetes with end organ 
damage 
o Moderate or severe renal 
disease 
o Hemiplegia  
o Diabetes without end organ 
damage 
o Mild liver disease 
o Ulcer disease 
o Connective tissue disease 
o Chronic pulmonary disease 
o Dementia 
o Cerebrovascular disease 
o Peripheral vascular disease 
o Congestive heart failure 
o Myocardial infarction   
 
25. Do your biological parent(s) have asthma? 
¨ Mother 
¨ Father 
¨ Both 
¨ Don’t know 
¨ Neither 
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26. Have you ever been hospitalized for your asthma? 
¨ Yes 
o If yes, how many times? _______________ 
¨ No  
 
27. Have you been hospitalized in the past year for your asthma? 
¨ Yes 
o If yes, how many times? _______________ 
¨ No  
 
28. Have you ever visited the emergency room for your asthma? 
¨ Yes 
o If yes, how many times? _______________ 
¨ No  
 
29. Have you visited the emergency room in the past year for your asthma? 
¨ Yes 
o If yes, how many times? _______________ 
¨ No  
 
30. Have you ever been intubated for your asthma? 
¨ Yes 
o If yes, how many times? _______________ 
¨ No  
 
31. Have you been intubated in the past year for your asthma? 
¨ Yes 
o If yes, how many times? _______________ 
¨ No  
 
32. How often do you see your physician for your asthma? 
¨ At least once per month 
¨ Once every 3 months 
¨ Once every 6 months 
¨ Once per year 
¨ Less than once per year 
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Medical Record Questionnaire 
 
1. What site is the participant a patient at? 
¨ Atlantic Research Center, LLC 
¨ Drexel Pulmonary Medicine 
¨ Cooper University Hospital, Camden 
¨ Cooper University Hospital, Voorhees 
 
2. Who is the patient’s primary physician at this location? 
 
a. ________________________ 
 
3. What is the patient’s asthma diagnosis? 
¨ Mild persistent 
¨ Moderate persistent 
¨ Severe persistent 
 
4. How many times has the patient refilled his/ her controller medication (ICS) prescription 
in the past 12 months? (Information obtained from pharmacy records). 
 
_____________ 
 
 
  
    
 
70
Medication Adherence Report Scale—Asthma (MARS-A)  
 
Questions about using your controller/ preventer inhaler: 
 
• Many people find a way of using their inhaler that suits them. 
• This may differ from the instructions on the label or from what their doctor has said. 
• We would like to ask you a few questions about how you use your inhaler.  
 
Here are some ways in which people have said that they use their controller inhaler.  
For each of the statements, please pick the answer that best applies to you.
 Always Often Sometimes Rarely Never 
1 I only use it when I need it. 
 
     
2 I only use it when I feel 
breathless. 
     
3 I decide to miss out a dose.  
 
     
4 I try to avoid using it. 
 
     
5 I forget to take it 
 
     
6 I alter the dose.  
 
     
7 I stop taking it for a while. 
 
     
8 I use it as a reserve, if my other 
treatment doesn’t work. 
     
9 I use it before doing something 
which might make me 
breathless. 
     
10 I take less than instructed.  
 
     
  
 
 
 
 
 
 
 
© Professor Rob Horne 
 
 
Copyright of MARS-A and all its variants is owned by the originator Robert Horne, PhD, and 
permission to use it should be obtained by requests to r.horne@ucl.ac.uk
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Social Problem-Solving Inventory-Revised: Short Form (SPSI-R:S) 
 
INSTRUCTIONS. Below are some ways that you might think, feel, and act when faced with 
problems in everyday living. We are not talking about the ordinary hassles and pressures that you 
handle successfully every day. In this questionnaire, a problem is something important in your 
life that bothers you a lot, but you don't immediately know how to make it better or stop it from 
bothering you so much. The problem could be something about yourself (your thoughts, feelings, 
behavior, health, or appearance), your relationships with other people (your family, friends, 
teachers, or boss), or your environment and the things you own (your house, car, or money).  
Please read each statement carefully and choose one of the numbers below that best shows how 
much the statement is true of you. See yourself as you usually think, feel, and act when you are 
faced with important problems in your life these days. Circle the number that is the most true of 
you. For example, using the following rating scale (which is at the top of each page), if you 
believe that the statement “Whenever I have a problem, I believe that it can be solved” is “Very 
True of Me,” then you would circle the number “3.”  
Not at All True 
of Me 
Slightly True of 
Me 
Moderately 
True of Me 
Very True of 
Me 
Extremely True 
of Me 
0 1 2 3 4 
 
 
1. I feel threatened and afraid when I have an important problem to solve.  
 
0 1 2 3 4 
2. When making decisions, I do not evaluate all of my options carefully enough. 
 
0 1 2 3 4 
3. I feel nervous and unsure of myself when I have an important decision to make. 
 
0 1 2 3 4 
4. When my first efforts to solve a problem fail, I know if I persist and do not give up too 
easily, I will be able to eventually find a good solution.  
 
0 1 2 3 4 
5. When I have a problem, I try to see it as a challenge, or opportunity to benefit in some 
positive way from having the problem.  
 
0 1 2 3 4 
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Not at All True 
of Me 
Slightly True of 
Me 
Moderately 
True of Me 
Very True of 
Me 
Extremely True 
of Me 
0 1 2 3 4 
 
6. I wait to see if a problem will resolve itself first, before trying to solve it myself. 
 
0 1 2 3 4 
7. When my first efforts to solve a problem fail, I get very frustrated.  
 
0 1 2 3 4 
8. When I am faced with a difficult problem, I doubt that I will be able to solve it on my 
own no matter how hard I try. 
 
0 1 2 3 4 
9. Whenever I have a problem, I believe that it can be solved.  
 
0 1 2 3 4 
10. I go out of my way to avoid having to deal with problems in my life.  
 
0 1 2 3 4 
11. Difficult problems make me very upset.  
 
0 1 2 3 4 
12. When I have a decision to make, I try to predict the positive and negative consequences 
of each option.  
 
0 1 2 3 4 
13. When problems occur in my life, I like to deal with them as soon as possible. 
 
0 1 2 3 4 
14. When I am trying to solve a problem, I go with the first good idea that comes to mind. 
 
0 1 2 3 4 
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Not at All True 
of Me 
Slightly True of 
Me 
Moderately 
True of Me 
Very True of 
Me 
Extremely True 
of Me 
0 1 2 3 4 
 
15. When I am faced with a difficult problem, I believe that I will be able to solve it on my 
own if I try hard enough.  
 
0 1 2 3 4 
16. When I have a problem to solve, one of the first things I do is get as many facts about the 
problem as possible.  
 
0 1 2 3 4 
17. When a problem occurs in my life, I put off trying to solve it for as long as possible. 
 
0 1 2 3 4 
18. I spend more time avoiding my problems than solving them.  
 
0 1 2 3 4 
19. Before I try to solve a problem, I set a specific goal so that I know exactly what I want to 
accomplish.  
 
0 1 2 3 4 
20. When I have a decision to make, I do not take the time to consider the pros and cons of 
each option. 
 
0 1 2 3 4 
21. After carrying out a solution to a problem, I try to evaluate as carefully as possible how 
much the situation has changed for the better. 
 
0 1 2 3 4 
22. I put off solving problems until it is too late to do anything about them.  
 
0 1 2 3 4 
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Not at All True 
of Me 
Slightly True of 
Me 
Moderately 
True of Me 
Very True of 
Me 
Extremely True 
of Me 
0 1 2 3 4 
 
23. When I am trying to solve a problem, I think of as many options as possible until I cannot 
come up with any more ideas.  
 
0 1 2 3 4 
24. When making decisions, I go with my “gut feeling” without thinking too much about the 
consequences of each option.  
 
0 1 2 3 4 
25. I am too impulsive when it comes to making decisions.  
 
0 1 2 3 4 
 
 
Please be sure that you completed all 25 questions.  
Thank you! 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reference: D’Zurilla, T. J., Nezu, A. M., & Maydeu-Olivares A. Social Problem-Solving 
Inventory – Revised (SPSI-R): Technical Manual. North Tonawanda, NY: Multi-Health 
Systems; 2002.  
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Asthma Control Test (ACT) 
 
The Asthma Control Test TM provides a numerical score to help you and your healthcare provider 
determine if your asthma symptoms are well controlled.  
 
1. In the past 4 weeks, how much of the time did your asthma keep you from getting as 
much done at work, school or at home? 
 
All of the time Most of the time Some of the time A little of the 
time 
None of the time 
1 2 3 4 5 
 
2. During the past 4 weeks, how often have you had shortness of breath? 
 
More than Once 
a day 
Once a day 3 to 6 times a 
week 
Once or twice a 
week 
Not at all 
1 2 3 4 5 
 
3. During the past 4 weeks, how often did your asthma symptoms (wheezing, coughing, 
shortness of breath, chest tightness or pain) wake you up at night or earlier than usual in 
the morning? 
 
4 or more nights 
a week 
2 to 3 nights a 
week 
Once a week Once or twice Not at all 
1 2 3 4 5 
 
4. During the past 4 weeks, how often have you used your rescue inhaler or nebulizer 
medication (such as albuterol)? 
 
3 or more times 
per day 
1 or 2 times per 
day 
2 or 3 times per 
week 
Once a week or 
less 
Not at all 
1 2 3 4 5 
 
5. How would you rate your asthma control during the past 4 weeks? 
 
Not Controlled 
at All 
Poorly 
Controlled 
Somewhat 
Controlled 
Well Controlled Completely 
Controlled 
1 2 3 4 5 
 
Copyright 2002, by QualityMetric Incorporated. 
Asthma Control Test is a trademark of QualityMetric Incorporated.  
This material was developed by GSK. 
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Perceived Control of Asthma Questionnaire (PCAQ) 
 
Strongly 
Agree 
Agree  Don’t know/ 
neutral 
Disagree  Strongly 
Disagree 
5 4 3 2 1 
 
1. I can reduce my asthma by staying calm and relaxed.  
 
5 4 3 2 1 
2. Too often, my asthma just seems to hit me out of the blue.  
 
5 4 3 2 1 
3. If I do all the right things, I can successfully manage my asthma.  
 
5 4 3 2 1 
4. I can do a lot of things myself to cope with my asthma.  
 
5 4 3 2 1 
5. When I manage my personal life well, my asthma does not affect me as much.  
 
5 4 3 2 1 
6. I have considerable ability to control my asthma.  
 
5 4 3 2 1 
7. I would feel helpless if I couldn’t rely on other people for help when I’m not feeling well 
from asthma.  
 
5 4 3 2 1 
8. No matter what I do, or how hard I try, I just can’t seem to get relief from my asthma.  
 
5 4 3 2 1 
9. I am coping effectively with my asthma.  
 
5 4 3 2 1 
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Strongly 
Agree 
Agree  Don’t know/ 
neutral 
Disagree  Strongly 
Disagree 
5 4 3 2 1 
 
10. It seems as though fate and other factors beyond my control affect my asthma.  
 
5 4 3 2 1 
11. Asthma is controlling my life.  
 
5 4 3 2 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
©Patricia Katz, 2002 
 
 
Reference: Katz, P. P., Yelin, E. H., Eisner, M. D., & Blanc, P. D. (2002). Perceived control of 
asthma and quality of life among adults with asthma. Annals of Allergy, Asthma & 
Immunology, 89(3), 251-258. 
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Perceived Stress Scale (PSS) 
 
Instructions: The questions in this scale ask you about your feelings and thoughts during the last 
month. In each case, you will be asked to indicate how often you felt or thought a certain way. 
Although some of the questions are similar, there are differences between them and you should 
treat each one as a separate question. The best approach is to answer each question fairly quickly. 
That is, don’t try to count up the number of times you felt a particular way, but rather indicate 
the alternative that seems like a reasonable estimate. For each question choose from the 
following alternatives:  
Never Almost 
Never 
Sometimes Fairly Often Very Often 
0 1 2 3 4 
 
1. In the last month, how often have you been upset because of something that happened 
unexpectedly?   
 
0 1 2 3 4 
2. In the last month, how often have you felt that you were unable to control the important 
things in your life?  
 
0 1 2 3 4 
3. In the last month, how often have you felt nervous and “stressed”?  
 
0 1 2 3 4 
4. In the last month, how often have you dealt successfully with irritating life hassles?   
 
0 1 2 3 4 
5. In the last month, how often have you felt that you were effectively coping with 
important changes that were occurring in your life?  
 
0 1 2 3 4 
6. In the last month, how often have you felt confident about your ability to handle your 
personal problems? 
0 1 2 3 4 
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Never Almost 
Never 
Sometimes Fairly Often Very Often 
0 1 2 3 4 
 
7. In the last month, how often have you felt that things were going your way? 
 
0 1 2 3 4 
8. In the last month, how often have you found that you could not cope with all the things 
that you had to do? 
 
0 1 2 3 4 
9. In the last month, how often have you been able to control irritations in your life? 
 
0 1 2 3 4 
10. In the last month, how often have you felt that you were on top of things? 
 
0 1 2 3 4 
11. In the last month, how often have you been angered because of things that happened that 
were outside of your control? 
 
0 1 2 3 4 
12. In the last month, how often have you found yourself thinking about things that you have 
to accomplish? 
 
0 1 2 3 4 
13. In the last month, how often have you been able to control the way you spend your time? 
 
0 1 2 3 4 
14. In the last month, how often have you felt difficulties were piling up so high that you 
could not overcome them?  
 
0 1 2 3 4 
Reference: Cohen, S., Kamarack, T., & Mermelstein, R. (1983). A global measure of perceived 
stress. Journal of Health and Social Behavior, 24(4), 385-396.  
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Contact	Sara	at:	
(215)	553-7123	
asthma.problemsolving@gmail.com	
Appendix B: Recruitment Flyer 
 
Do you have a diagnosis of Asthma? 
 
If so, you may qualify to participate in a research study. 
 
Drexel University is recruiting volunteers to participate in a research study about 
social problem-solving, stress, asthma control, and medication adherence.  
 
Research Goals:  
 
The purpose of this research study is to better understand how the ways in 
which people solve real-life problems and the experience of perceived stress 
can impact medication adherence behaviors. This information may be helpful 
in the development of programs to improve medication adherence in asthma 
patients.  
 
Participation involves completing a one-time survey that asks questions about 
how you typically solve problems in your life, how controlled your asthma is, 
your current levels of perceived stress, and medication-taking tendencies. 
 
Eligibility:  
 
You may be able to participate in this research study if you… 
ü Have a diagnosis of mild, moderate or severe persistent asthma 
ü Are 18 years of age or older 
ü Are able to read and understand English on at least a 4th grade level 
ü Are prescribed a daily controller inhaler (ICS) 
Interested in participating? 
 
Let your physician know if you would like to be contacted by the research team 
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